<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutrients</journal-id><journal-id journal-id-type="iso-abbrev">Nutrients</journal-id><journal-id journal-id-type="pmc-domain-id">1692</journal-id><journal-id journal-id-type="pmc-domain">nutrients</journal-id><journal-id journal-id-type="publisher-id">nutrients</journal-id><journal-title-group><journal-title>Nutrients</journal-title></journal-title-group><issn pub-type="epub">2072-6643</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12430659</article-id><article-id pub-id-type="pmcid-ver">PMC12430659.1</article-id><article-id pub-id-type="pmcaid">12430659</article-id><article-id pub-id-type="pmcaiid">12430659</article-id><article-id pub-id-type="doi">10.3390/nu17172829</article-id><article-id pub-id-type="publisher-id">nutrients-17-02829</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Dietary Tart Cherry and Fructooligosaccharides Promote Bone Health via the Gut Microbiota and Increased Bone Formation</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Adedigba</surname><given-names initials="P">Pelumi</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="af1-nutrients-17-02829" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0066-9121</contrib-id><name name-style="western"><surname>Ice</surname><given-names initials="JA">John A.</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="af2-nutrients-17-02829" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Alake</surname><given-names initials="SE">Sanmi E.</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="af2-nutrients-17-02829" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hatter</surname><given-names initials="B">Bethany</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="af2-nutrients-17-02829" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Islam</surname><given-names initials="P">Proapa</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="af2-nutrients-17-02829" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9059-5703</contrib-id><name name-style="western"><surname>Ford Versypt</surname><given-names initials="AN">Ashlee N.</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af3-nutrients-17-02829" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Knotts</surname><given-names initials="TA">Trina A.</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="af4-nutrients-17-02829" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ritchey</surname><given-names initials="J">Jerry</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af5-nutrients-17-02829" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4983-1193</contrib-id><name name-style="western"><surname>Lucas</surname><given-names initials="EA">Edralin A.</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af2-nutrients-17-02829" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-7296-8534</contrib-id><name name-style="western"><surname>Smith</surname><given-names initials="BJ">Brenda J.</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af1-nutrients-17-02829" ref-type="aff">1</xref><xref rid="af6-nutrients-17-02829" ref-type="aff">6</xref><xref rid="c1-nutrients-17-02829" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Chen</surname><given-names initials="Y">Yuming</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-nutrients-17-02829"><label>1</label>Indiana Center for Musculoskeletal Health, Indiana School of Medicine, Indianapolis, IN 46202, USA; <email>padedigb@iu.edu</email></aff><aff id="af2-nutrients-17-02829"><label>2</label>Nutritional Sciences Department, Oklahoma State University, Stillwater, OK 74078, USA; <email>john.ice@va.gov</email> (J.A.I.); <email>sanmi.alake@okstate.edu</email> (S.E.A.); <email>bhatter@ostatemail.okstate.edu</email> (B.H.); <email>proapa.islam@okstate.edu</email> (P.I.); <email>edralin.a.lucas@okstate.edu</email> (E.A.L.)</aff><aff id="af3-nutrients-17-02829"><label>3</label>Department of Chemical and Biological Engineering, University at Buffalo, Buffalo, NY 14260, USA; <email>ashleefv@buffalo.edu</email></aff><aff id="af4-nutrients-17-02829"><label>4</label>Department of Surgery, Center for Alimentary and Metabolic Science, UC Davis Health, Sacramento, CA 95817, USA; <email>taknotts@ucdavis.edu</email></aff><aff id="af5-nutrients-17-02829"><label>5</label>Veterinary Pathobiology Department, Oklahoma State University, Stillwater, OK 74078, USA; <email>jerry.ritchey@okstate.edu</email></aff><aff id="af6-nutrients-17-02829"><label>6</label>Department of Obstetrics and Gynecology, Indiana School of Medicine, Indianapolis, IN 46202, USA</aff><author-notes><corresp id="c1-nutrients-17-02829"><label>*</label>Correspondence: <email>bsm14@iu.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>30</day><month>8</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><volume>17</volume><issue>17</issue><issue-id pub-id-type="pmc-issue-id">495755</issue-id><elocation-id>2829</elocation-id><history><date date-type="received"><day>01</day><month>8</month><year>2025</year></date><date date-type="rev-recd"><day>26</day><month>8</month><year>2025</year></date><date date-type="accepted"><day>29</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>30</day><month>08</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 17:25:36.317"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nutrients-17-02829.pdf"/><abstract><p><bold>Background/Objectives:</bold> Fructooligosaccharides (FOS) and dried tart cherry (TC) are examples of simple and complex (i.e., within a food matrix) prebiotics that have demonstrated promising osteoprotective activity. In this study, we examined how dietary supplementation with TC or FOS shapes the gut-bone axis to promote bone accrual in young adult mice, and the role of the gut microbiota in mediating these responses. <bold>Methods:</bold> Studies were performed using 10-wk-old female C57BL/6 mice (n = 10&#8211;12/group) fed a control diet or control diet supplemented with 10% TC or FOS for 10 wks alone or in combination with an antibiotic/anti-fungal cocktail to suppress the gut microbiota. The bone phenotype was characterized by dual-energy X-ray absorptiometry, micro-computed tomography and static and dynamic bone histomorphometry. The gut-microbiota was profiled and short chain fatty acids (SCFA) were assessed based on 16S rRNA profiling and gas chromatographic techniques, respectively. <bold>Results:</bold> FOS and TC enhanced bone structure, with FOS yielding more pronounced benefits across cortical and trabecular compartments. These skeletal improvements with FOS occurred in the absence of systemic changes in bone turnover markers but were accompanied by increases in local bone formation, osteoblast and osteocyte numbers, and bone mineralization in the femur. Both diets altered gut microbiota composition and increased fecal concentrations of the most abundant SCFAs (i.e., acetate, propionate and butyrate), but the response was greater with FOS. Suppression of the gut microbiota and fecal SCFAs with the antibiotic/anti-fungal cocktail inhibited the effects of FOS and TC on cortical bone, but induced unexpected improvements in the trabecular bone. <bold>Conclusions:</bold> These findings demonstrate differential effects of simple and complex prebiotics on the gut-bone axis in young adult female mice and support a role for SCFA in the cortical bone response, but not in the trabecular bone response with this model of gut microbiota suppression.</p></abstract><kwd-group><kwd>gut-bone axis</kwd><kwd>prebiotics</kwd><kwd>microbiota</kwd><kwd>antibiotics</kwd><kwd>short chain fatty acids</kwd><kwd>fructooligosaccharides</kwd><kwd>tart cherry</kwd><kwd>osteocytes</kwd><kwd>histomorphometry</kwd></kwd-group><funding-group><award-group><funding-source>National Center for Complementary and Integrative Health (NCCIH)</funding-source><award-id>R15AT010725</award-id></award-group><award-group><funding-source>Office of Dietary Supplements (ODS) of the National Institutes of Health</funding-source><award-id>R15AT010725-S1</award-id></award-group><funding-statement>This research was supported by the National Center for Complementary and Integrative Health (NCCIH) and the Office of Dietary Supplements (ODS) of the National Institutes of Health under Award Numbers R15AT010725 (NCCIH) and R15AT010725-S1 (ODS). The contents are solely the responsibility of the authors and do not represent the official views of the National Institutes of Health.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-nutrients-17-02829"><title>1. Introduction</title><p>The gut microbiota plays a crucial role in maintaining bone tissue by influencing key processes, including bone formation and resorption [<xref rid="B1-nutrients-17-02829" ref-type="bibr">1</xref>,<xref rid="B2-nutrients-17-02829" ref-type="bibr">2</xref>]. These effects can be mediated through systemic factors, including gut-derived metabolites, hormones, and cytokines, as well as and local signaling pathways (e.g., Wnt signaling and osteoclastogenesis) that regulate bone homeostasis [<xref rid="B3-nutrients-17-02829" ref-type="bibr">3</xref>,<xref rid="B4-nutrients-17-02829" ref-type="bibr">4</xref>,<xref rid="B5-nutrients-17-02829" ref-type="bibr">5</xref>]. In the absence or ablation of the gut microbiota as in the case of germ-free (GF) mice or mice on antibiotic (ABX) treatment, bone mass, biomechanical properties, and microarchitecture are altered [<xref rid="B1-nutrients-17-02829" ref-type="bibr">1</xref>,<xref rid="B2-nutrients-17-02829" ref-type="bibr">2</xref>,<xref rid="B6-nutrients-17-02829" ref-type="bibr">6</xref>]. Drugs, such as glucocorticoids that are used in the treatment of chronic inflammatory conditions (e.g., inflammatory bowel disease, rheumatoid arthritis, and chronic obstructive pulmonary disease) and the bone anabolic agent intermittent parathyroid hormone (iPTH), have been reported to mediate their effects on the bone through the gut microbiota [<xref rid="B7-nutrients-17-02829" ref-type="bibr">7</xref>,<xref rid="B8-nutrients-17-02829" ref-type="bibr">8</xref>]. For instance, chronic glucocorticoid use induces bone loss and imbalances in intestinal microbial communities, which leads to a compromise in the gut barrier. Administration of probiotics and prebiotics restored the gut barrier and prevented bone loss [<xref rid="B9-nutrients-17-02829" ref-type="bibr">9</xref>,<xref rid="B10-nutrients-17-02829" ref-type="bibr">10</xref>]. Additionally, postmenopausal women with osteoporosis have reduced microbiota diversity and increased intestinal permeability compared to age-matched controls without osteoporosis, suggesting a link between gut dysbiosis and postmenopausal osteoporosis development [<xref rid="B11-nutrients-17-02829" ref-type="bibr">11</xref>,<xref rid="B12-nutrients-17-02829" ref-type="bibr">12</xref>]. Mechanical loading, which has been shown to promote bone formation and increase bone mass, fails to achieve these effects in mice depleted of their gut microbiota [<xref rid="B13-nutrients-17-02829" ref-type="bibr">13</xref>]. Combined, this growing body of pre-clinical and clinical evidence highlights the role of the gut microbiota as a key regulator of skeletal health and a promising target for dietary interventions.</p><p>Prebiotics are non-digestible food components that selectively stimulate the growth and activity of beneficial gut microbiota, by serving as substrates that can modulate immune responses, improve gut barrier integrity, and improve some aspects of the host&#8217;s health [<xref rid="B5-nutrients-17-02829" ref-type="bibr">5</xref>,<xref rid="B14-nutrients-17-02829" ref-type="bibr">14</xref>]. Prebiotics can be classified based on their composition as either simple or complex. Simple prebiotics include a single class of compounds such as fructooligosaccharides (FOS), galactooligosaccharides (GOS), resistant starch, polyphenols, or other phytochemicals. In contrast, complex prebiotic sources are typically prebiotics that exists within a food matrix (e.g., chicory, tart cherries, plums, onions and garlic), which can influence where and how rapidly they are metabolized [<xref rid="B15-nutrients-17-02829" ref-type="bibr">15</xref>,<xref rid="B16-nutrients-17-02829" ref-type="bibr">16</xref>].</p><p>The simple prebiotic, FOS, composed of linear fructose oligomers has been studied for its benefits on bone health [<xref rid="B17-nutrients-17-02829" ref-type="bibr">17</xref>,<xref rid="B18-nutrients-17-02829" ref-type="bibr">18</xref>]. In ovarian hormone deficient rats, FOS enhanced intestinal calcium and magnesium absorption, increased bone mineral content, and suppressed bone resorption [<xref rid="B19-nutrients-17-02829" ref-type="bibr">19</xref>,<xref rid="B20-nutrients-17-02829" ref-type="bibr">20</xref>,<xref rid="B21-nutrients-17-02829" ref-type="bibr">21</xref>]. Clinical studies have linked FOS intake to higher bone mineral density (BMD) in adolescents and reduced bone turnover markers in postmenopausal women [<xref rid="B22-nutrients-17-02829" ref-type="bibr">22</xref>,<xref rid="B23-nutrients-17-02829" ref-type="bibr">23</xref>]. Recently, we reported that a short chain FOS that is enzymatically synthesized from sucrose, enhances bone accrual in young adult female mice in conjunction with increasing osteocyte density and regulators of osteoblast differentiation and activity in young adult mice [<xref rid="B24-nutrients-17-02829" ref-type="bibr">24</xref>]. The beneficial effects of FOS on the gut-bone axis have been attributed primarily to alterations in the gut microbiota composition and the subsequent fermentation of non-digestible carbohydrates to produce short-chain fatty acids (SCFAs) [<xref rid="B24-nutrients-17-02829" ref-type="bibr">24</xref>,<xref rid="B25-nutrients-17-02829" ref-type="bibr">25</xref>].</p><p>Tart cherries (<italic toggle="yes">Prunus cerasus</italic>; TC) are regarded as a fruit with potential prebiotic activity that improves bone health, through its fermentable fibers and polyphenols that support gut microbiota metabolism [<xref rid="B26-nutrients-17-02829" ref-type="bibr">26</xref>,<xref rid="B27-nutrients-17-02829" ref-type="bibr">27</xref>]. TC is widely recognized for its health-promoting properties, primarily attributed to its anti-inflammatory and antioxidant effects [<xref rid="B28-nutrients-17-02829" ref-type="bibr">28</xref>,<xref rid="B29-nutrients-17-02829" ref-type="bibr">29</xref>]. In addition to providing some FOS (0.33 g/100 g), TC contains a diverse profile of polyphenolic compounds, including anthocyanins and hydroxycinnamic acids, that have prebiotic activity, influencing gut microbiota composition and function [<xref rid="B26-nutrients-17-02829" ref-type="bibr">26</xref>,<xref rid="B30-nutrients-17-02829" ref-type="bibr">30</xref>,<xref rid="B31-nutrients-17-02829" ref-type="bibr">31</xref>,<xref rid="B32-nutrients-17-02829" ref-type="bibr">32</xref>]. Preclinical evidence suggests that these compounds can enhance the production of gut-derived metabolites, including SCFAs, which support intestinal and systemic health [<xref rid="B33-nutrients-17-02829" ref-type="bibr">33</xref>,<xref rid="B34-nutrients-17-02829" ref-type="bibr">34</xref>]. TC have been investigated in several clinical trials, with studies reporting potential benefits on vascular function in men, muscle recovery in male and female runners, sleep quality, and the management of osteoarthritis [<xref rid="B29-nutrients-17-02829" ref-type="bibr">29</xref>,<xref rid="B35-nutrients-17-02829" ref-type="bibr">35</xref>,<xref rid="B36-nutrients-17-02829" ref-type="bibr">36</xref>,<xref rid="B37-nutrients-17-02829" ref-type="bibr">37</xref>,<xref rid="B38-nutrients-17-02829" ref-type="bibr">38</xref>,<xref rid="B39-nutrients-17-02829" ref-type="bibr">39</xref>]. We reported that consuming tart cherry juice for 90 d reduced serum tartrate resistant acid phosphatase 5b (TRAP5b), a bone resorption marker, in postmenopausal women [<xref rid="B40-nutrients-17-02829" ref-type="bibr">40</xref>]. In preclinical studies, our lab and others have shown that TC supplementation protects against age-related trabecular bone loss and the deterioration of bone associated with inflammation in a mouse model of rheumatoid arthritis [<xref rid="B27-nutrients-17-02829" ref-type="bibr">27</xref>,<xref rid="B40-nutrients-17-02829" ref-type="bibr">40</xref>,<xref rid="B41-nutrients-17-02829" ref-type="bibr">41</xref>].</p><p>FOS and TC represent examples of simple and complex prebiotics that have each been shown to exert beneficial effects on bone in both pre-clinical and clinical studies. Despite their effects on bone, a comparison of their influence on the gut microbiota and the mechanisms through which their effects on bone are mediated have not been investigated. Thus, it is important to investigate how dietary supplementation of these two very different prebiotics affects bone structural properties and remodeling and the role of the microbiota in these responses.</p></sec><sec id="sec2-nutrients-17-02829"><title>2. Materials and Methods</title><sec id="sec2dot1-nutrients-17-02829"><title>2.1. Animal Care and Experimental Design</title><p>All procedures adhered to the guidelines set forth by the Oklahoma State University (OSU) Institutional Care and Animal Use Committee. Eight-week-old female C57BL/6 mice (n = 96; Taconic Biosciences, Germantown, NY, USA) were acclimated for 2 weeks and fed one of three diets: control diet (CON; AIN-93M), tart cherry (TC; 10% <italic toggle="yes">w</italic>/<italic toggle="yes">w</italic>), or short chain FOS (10% <italic toggle="yes">w</italic>/<italic toggle="yes">w</italic>) for 10 wks. Pitted flash-frozen Montmorency tart cherries were purchased (Shoreline Fruits at Peterson Farms, Shelby, MI, USA), lyophilized, and ground into powder. FOS (NUTRAFLORA<sup>&#174;</sup>, FB P-95, Ingredion Inc., Westchester, IL, USA) was purchased in powder form. Diets were formulated based on the semi-purified AIN-93M diet and adjusted to have similar macronutrient, calcium, and phosphorous content [<xref rid="B42-nutrients-17-02829" ref-type="bibr">42</xref>]. A separate set of mice had antibiotics (ABX) added to their drinking water to further investigate the role of the gut microbiota in the response to FOS and TC. The antibiotic cocktail included metronidazole (1 mg/mL; Cayman Chemical, Ann Arbor, MI, USA 9002409), ampicillin (1 mg/mL; Cayman Chemical 14417), vancomycin (0.5 mg/mL; VWR V0990), and neomycin (1 mg/mL; N6386 Sigma Aldrich, St. Louis, MO, USA), incorporated into the drinking water. This cocktail has been shown to suppress almost all bacteria population within the gut [<xref rid="B43-nutrients-17-02829" ref-type="bibr">43</xref>,<xref rid="B44-nutrients-17-02829" ref-type="bibr">44</xref>]. An anti-fungal, amphotericin B (0.01 mg/mL; Sigma Aldrich A9528), was also added to the cocktail to reduce the risk of overgrowth of fungi with the suppression of bacterial communities within the gastrointestinal tract as has been reported [<xref rid="B45-nutrients-17-02829" ref-type="bibr">45</xref>]. Mice were group housed (four mice/cage) using a wire grid on top of the bedding in shoe-box cages to avoid coprophagy and had access to deionized water ad libitum. Food intake was recorded daily, and body weights were recorded on a weekly basis. Animals were housed in the OSU Laboratory Animal Research Facility with controlled access and environmental conditions (12-h light and dark cycle).</p><p>At the end of the study, fecal samples were collected and stored at &#8722;80 &#176;C for SCFA analysis. Mice were fasted for 3 h and anesthetized with ketamine/xylazine cocktail (100 mg/10 mg per kg bodyweight). Whole body dual-energy X-ray absorptiometry (DXA) scans (LunarPIXI, GE Medical Systems, Madison, WI, USA) were performed, and mice were exsanguinated via the carotid artery. Blood was processed for serum prior to storage at &#8722;80 &#176;C for future analysis. Cecal contents were flushed with ice cold, sterile PBS, centrifuged and the supinate decanted prior to weighing and storage at &#8722;80 &#176;C for microbiota profiling. One femur specimen was cleaned of soft tissues, and the bone marrow was flushed with ice cold Dulbecco&#8217;s Modified Eagle Medium (DMEM) media and processed for fluorescence activated cell sorting (FACS) analysis. The second femur and the 5th lumbar vertebra were collected, cleaned of soft tissue, and either stored in 70% ethanol or fixed in 10% neutral buffered formalin (NBF) and stored for micro-computed tomography (&#181;CT) (&#181;CT40, SCANCO Medical, Wangen Bruttisellen, Switzerland). Following flushing of the intestine with ice cold PBS, the ileum was collected, Peyer&#8217;s patches were removed, and the remaining ileum was processed for FACS analysis. The colon length was measured, and the lamina propria was collected and stored in RNAlater for gene expression analysis.</p></sec><sec id="sec2dot2-nutrients-17-02829"><title>2.2. Whole Body Composition and Bone Densitometry Assessment</title><p>Whole body DXA scans were analyzed to assess body composition (i.e., lean mass, fat mass, and body fat percentage), bone mineral area (BMA), content (BMC), and density (BMD) with Series Software Version 1.4x (GE Lunar PixiMus, Madison, WI, USA).</p></sec><sec id="sec2dot3-nutrients-17-02829"><title>2.3. Micro-Computed Tomography (&#181;CT) Analyses</title><p>Quantification of trabecular and cortical bone microarchitecture within the femur and the fifth lumbar vertebra was performed using X-ray &#181;CT. The distal femoral metaphysis and mid-diaphysis were used to analyze trabecular and cortical bones, respectively. Scans of the femoral distal metaphysis were performed at a resolution of 2048 &#215; 2048 pixels and were analyzed by evaluating approximately 140 slices (0.840 mm) within the volume of interest (VOI). Analysis of the lumbar vertebra was performed by acquiring images at a resolution of 1024 &#215; 1024 pixels and a VOI of approximately 170 slices (2.7 mm) medial to the dorsal and caudal growth plates. Only the secondary spongiosa was considered for trabecular bone analysis. Trabecular bone parameters included bone volume per total volume (BV/TV), trabecular number (TbN), trabecular thickness (TbTh), trabecular space (TbSp), connectivity density (ConnDens), and structural model index (SMI). The cortical bone of the femur was evaluated by analyzing approximately 30 slices (180 &#956;m) within the VOI at mid-diaphysis. Cortical bone parameters accessed included cortical porosity, thickness, area, and the medullary cavity area. All &#181;CT analyses utilized a threshold of 350, with a sigma of 1.2 and a support of 2.0.</p></sec><sec id="sec2dot4-nutrients-17-02829"><title>2.4. Serum Bone Biomarkers</title><p>Systemic biomarkers were assessed in serum samples collected at the end of the study using commercially available ELISA kits. These included biomarkers of osteoblast activity (P1NP), osteoclast activity (CTX-I) (Immunodiagnostic Systems Inc., Fountain Hills, AZ, USA), insulin-like growth factor-1 (IGF-1) (R&amp;D Systems, Minneapolis, MN, USA), and IGF binding protein-3 (IGFBP-3) (Sigma-Aldrich).</p></sec><sec id="sec2dot5-nutrients-17-02829"><title>2.5. Gut Microbiota Analyses</title><p>Total DNA isolation was carried out on frozen cecal samples using the QIAamp PowerFecal DNA kit (Qiagen, Hilden, Germany) according to manufacturer&#8217;s instructions. Sample libraries were prepared and analyzed by barcoded amplicon sequencing at the Mouse Metabolic Phenotyping Center, University of California, Davis (Davis, CA, USA). The DNA samples were purified and the V4 region of the 16s rRNA amplified using PCR with the following primers: F341 (5&#8242;-CCTACGGGNGGCWGCAG-3&#8242;) and R806 (5&#8242;-GGACTACNVGGGTWTCTAAT-3&#8242;). High-throughput sequencing was performed with Ilumina MiSeq paired end 250-bp run. Data derived from sequencing was processed using QIIME2 for 16S based microbiota analyses. Demultiplexed paired end sequences with barcodes and adapters removed were analyzed using Qiime 2 version 2023.5.1. DADA2 package version 1.26.0 was used for quality filtering and generating amplicon sequence variants. Taxonomic classification of OTUs was done with a pre-trained Na&#239;ve Bayes taxonomy classifier called the Silva_138_99% OTUs. Diversity analyses were run on the resulting OTU/feature.biom tables to provide both phylogenetic and non-phylogenetic metrics of alpha and beta diversity. Tables of taxonomic counts and percentage (relative frequency) were generated.</p></sec><sec id="sec2dot6-nutrients-17-02829"><title>2.6. Fecal SCFA Analyses</title><p>Fecal SCFAs were assessed using gas chromatography techniques as previously described [<xref rid="B46-nutrients-17-02829" ref-type="bibr">46</xref>]. Briefly, samples were lyophilized and granulated into a powder, and 150 mg was used in the assay. Next, 250 &#181;L of 7.14 M sulfuric acid, 45 &#181;L internal standard (1 mM 2-ethyl butyric acid in 12% formic acid) was added to the tube, followed by two rounds of extraction with 1 mL diethyl ether. Aliquots of approximately 500 &#181;L of the organic phase were collected into a GC sample vial and transferred to an Agilent 6890N GC system with flame ionization detector and automatic liquid sampler (Agilent Technologies, Santa Clara, CA, USA) for analysis. A 5-point calibration was performed using standard solutions of acetic, propionic, butyric, and valeric acids (Sigma-Aldrich).</p></sec><sec id="sec2dot7-nutrients-17-02829"><title>2.7. Intestinal Bacterial Load</title><p>To determine whether the antibiotic cocktail suppressed the gut microbiota within each diet group, a bacterial load assay was performed on fecal and cecal samples [<xref rid="B47-nutrients-17-02829" ref-type="bibr">47</xref>]. In short, genomic DNA was extracted from fecal and cecal contents using the QIAamp PowerFecal DNA Kit (QIAGEN), following the manufacturer&#8217;s protocol. The method used to evaluate DNA quantity was spectrophotometric analysis; DNA concentration and purity were measured using a NanoDrop spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA).</p></sec><sec id="sec2dot8-nutrients-17-02829"><title>2.8. Dynamic and Static Bone Histomorphometry</title><p>For histomorphometric analysis, fluorochrome labeling of the bones was performed by subcutaneous injections of calcein and alizarin red, administered 7 and 2 days before sacrifice. A subset of femurs from each group were dissected, fixed, and embedded in methyl methacrylate. Static histomorphometric analysis of non-decalcified bone sections was performed in the distal femur metaphysis. Von Kossa stain was performed and osteocytes and osteoblasts quantified. Silver nitrate stain was used for visualizing osteocyte lacuna and the canalicular system. Femur samples were processed at the Indiana Center for Musculoskeletal Health Histology and Histomorphometry Core. Histomorphometric analysis was performed using an OsteoMeasure high resolution digital video system (OsteoMetrics Inc., Decatur, GA, USA) applying units recommended by the Histomorphometry Nomenclature Committee of the American Society for Bone and Mineral Research [<xref rid="B48-nutrients-17-02829" ref-type="bibr">48</xref>].</p></sec><sec id="sec2dot9-nutrients-17-02829"><title>2.9. Flow Cytometry</title><p>Bone marrow was flushed using incomplete DMEM media. Red blood cells (RBCs) and platelets were subjected to lysis in a dark environment at room temperature for a duration of 5 min, using lysing buffer (BD Bioscience, Franklin Lakes, NJ, USA). To halt the RBC lysis process, incomplete DMEM was added, followed by centrifugation. The resulting cell pellet was re-suspended in 2 mL of complete media composed of DMEM media, 0.5% BSA, and 10 mM EDTA, pH adjusted to 7.4.</p><p>The ileum was flushed with RPMI medium, 2% FBS, and 1 mM dithiothreitol (DTT), and the Peyer&#8217;s patches and adhering fat tissues were removed. Excised ileal sections were incubated with HBSS (without phenol red) + 5 mM EDTA (pH~7.4) at room temperature to remove epithelial cells, followed by 0.20 mg/mL collagenase type VII digestion (Sigma-Aldrich), a process that was repeated &#215;3. Cells were collected, resuspended, and filtered through a sterile 70 &#181;m filter and subjected to separation on gradients containing 40% Percoll (20 mL 100% Percoll, 30 mL HBSS with phenol red) and 80% Percoll (40 mL 100% Percoll, 10 mL HBSS). Lymphocytes located at the interface of these gradients were collected and subsequently washed three times with complete media.</p><p>Viable cells from the bone marrow and ileum (2 &#215; 10<sup>6</sup>/sample) were transferred into 12 &#215; 70 mm round bottom FACS tube and incubated with live/dead stain for 30 min. Next, the cells underwent staining with surface markers (CD3, CD4, CD8, and CD25). Subsequently, cells were fixed using the mouse FOXP3 fixation/permeabilization buffer (BD Biosciences) for 30 min and protected from light. Cells were then stained for FOXP3, ROR&#947;t, and IL-17. Antibodies used included CD3e&#8211;eFluor 450 and FOXP3&#8211;eFluor 660 (eBioscience, San Diego, CA, USA), CD4&#8211;PerCP-Cy5.5 and CD25&#8211;PE-Cy7 (BD Biosciences), and CD8&#8211;Alexa Fluor 488 and IL-17A&#8211;PE (BioLegend, San Diego, CA, USA). Flow cytometry was performed using a BD FACSAria III (BD Biosciences) at the Core Flow Cytometry Laboratory, Center for Veterinary Health Sciences, Oklahoma State University. Data were analyzed with FlowJo (v10.8), using fluorescence minus one (FMO) and unstained controls for gating.</p></sec><sec id="sec2dot10-nutrients-17-02829"><title>2.10. Statistical Analysis</title><p>All data, with the exception of the microbiota data, were analyzed using SAS software (Version 9.43). Prior to analyses, outliers defined as values greater than &#177;2 SD from the mean were excluded from analyses. Assumptions of normality and equal variance were evaluated using the Shapiro-Wilks and Levene&#8217;s tests, respectively. Data not meeting normality assumptions were log-transformed; if normality assumptions were still unmet, Friedman&#8217;s test was applied.</p><p>For cecal microbiota analysis, alpha and beta diversity metrics were calculated using the QIIME pipeline (QIIME 2). Rarefaction was performed to standardize sequencing depth across samples, with a sampling depth set at 23,580 sequences per sample. Alpha diversity was assessed using the Shannon index, while beta diversity was evaluated using the Jaccard index followed by PERMANOVA pairwise comparisons. Differences in taxonomic abundance at multiple levels (Phylum, Class, Order, Family, Genus, and Species) were analyzed using the Analysis of Composition of Microbiomes with Bias Correction (ANCOM-BC). To control multiple comparisons, adjusted <italic toggle="yes">p</italic>-values were calculated using the Benjamini&#8211;Hochberg (BH) method.</p><p>The effects of dietary treatments (CON, TC, or FOS) were assessed using one-way ANOVA, and post hoc comparison was conducted using Tukey&#8217;s test. <italic toggle="yes">t</italic>-tests were performed on outcomes of interest to understand the influence of the ABX cocktail on bone phenotype of mice consuming the control diet (CON vs. CONABX). Next, we assessed the role of gut microbiota in diet-induced changes in body composition and the bone phenotype, using two-way ANOVA with Diet and ABX as factors. Where statistically significant Diet &#215; ABX interactions were observed, post hoc comparisons were conducted using Tukey&#8217;s test (<italic toggle="yes">p</italic> &lt; 0.05). Finally, because of the exploratory nature of the dynamic and static bone histomorphometry analysis utilizing n = 4 mice/group, <italic toggle="yes">t</italic>-tests comparing either FOS or TC to the CON were performed. All data are presented as mean &#177; standard error, with &#945; set at 0.05.</p></sec></sec><sec sec-type="results" id="sec3-nutrients-17-02829"><title>3. Results</title><sec id="sec3dot1-nutrients-17-02829"><title>3.1. FOS and TC Alter Body Composition and Bone Phenotype</title><p>All diet groups gained weight throughout the 10-wk study. However, by the third week the FOS treated group had lower bodyweight (<italic toggle="yes">p</italic> &lt; 0.05) compared to mice on the TC and CON diets (<xref rid="nutrients-17-02829-f001" ref-type="fig">Figure 1</xref>A). Slower weight gain in this group persisted throughout the remainder of the study. The lower body weight exhibited in the FOS-treated mice coincided with less whole body fat mass (<italic toggle="yes">p</italic> &lt; 0.0001) (<xref rid="nutrients-17-02829-f001" ref-type="fig">Figure 1</xref>B) and a lower percentage of body fat (<italic toggle="yes">p</italic> &lt; 0.0001) (<xref rid="app1-nutrients-17-02829" ref-type="app">Supplementary Table S1</xref>) compared to the TC and CON groups at the end of the study. Interestingly, there was no difference in lean mass between groups, indicating that the lower bodyweight in the FOS group was due to alterations in body fat only and not lean mass (<xref rid="nutrients-17-02829-f001" ref-type="fig">Figure 1</xref>C).</p><p>At the end of the study, whole body DXA scans revealed that the FOS group had a higher whole-body BMD (<italic toggle="yes">p</italic> &lt; 0.0001) compared to the TC and CON diet groups (<xref rid="nutrients-17-02829-f001" ref-type="fig">Figure 1</xref>D). This was due to mice consuming the FOS diet having higher whole-body BMC (<italic toggle="yes">p</italic> &lt; 0.0001) compared to CON, but there was no difference in BMC between the FOS and TC groups (<xref rid="nutrients-17-02829-f001" ref-type="fig">Figure 1</xref>E). There were also no observable effects of dietary treatment on whole body BMA (<xref rid="nutrients-17-02829-f001" ref-type="fig">Figure 1</xref>F). </p><p>To further understand the effects of the dietary treatments on bone microarchitecture, &#181;CT imaging was used to assess alterations in the trabecular bone within the axial skeleton (i.e., lumbar vertebrae), and the trabecular and cortical bone structural characteristics in appendicular skeleton (i.e., femur) following 10 wks of treatment. In the lumbar vertebrae, FOS and TC dietary treatments improved trabecular BV/TV (<italic toggle="yes">p</italic> &lt; 0.05) compared to CON, but the magnitude of the response was greater with the FOS treatment compared to the TC (<xref rid="nutrients-17-02829-f001" ref-type="fig">Figure 1</xref>G). The FOS group had higher TbTh (<italic toggle="yes">p</italic> &lt; 0.0001) than the TC and CON groups, but there were no effects of dietary treatment on TbN and TbSp (<xref rid="app1-nutrients-17-02829" ref-type="app">Supplementary Table S1</xref>). Trabecular connectivity density within the vertebral body was higher (<italic toggle="yes">p</italic> &lt; 0.05) in FOS and TC groups compared to CON mice. Mice on the FOS- and TC-supplemented diets also had lower trabecular bone SMI (<italic toggle="yes">p</italic> &lt; 0.0001) compared to CON (<xref rid="app1-nutrients-17-02829" ref-type="app">Supplementary Table S1</xref>), which is consistent with a more plate-like and potentially biomechanically stronger structure. In the distal femur metaphysis, the FOS and TC treated groups also exhibited an improved trabecular BV/TV (<xref rid="nutrients-17-02829-f001" ref-type="fig">Figure 1</xref>H). The FOS and TC groups had higher TbN (<italic toggle="yes">p</italic> &lt; 0.05) compared to the CON group, with the changes being more pronounced in the FOS group (<xref rid="app1-nutrients-17-02829" ref-type="app">Supplementary Table S1</xref>). While there were no differences in TbTh between the CON and FOS groups, TC exhibited lower TbTh (<italic toggle="yes">p</italic> &lt; 0.01) than the other dietary groups. TbSp was lower in the FOS and TC groups (<italic toggle="yes">p</italic> &lt; 0.0001) compared to CON. Trabecular connectivity density within the femur was higher (<italic toggle="yes">p</italic> &lt; 0.01) in FOS and TC treated mice compared to CON. The FOS group also had a lower SMI (<italic toggle="yes">p</italic> &lt; 0.05) compared to CON (<xref rid="app1-nutrients-17-02829" ref-type="app">Supplementary Table S1</xref>).</p><p>Cortical bone was evaluated at the femur mid-diaphysis. Only mice fed the FOS diet had higher cortical thickness and area (<italic toggle="yes">p</italic> &lt; 0.05) compared to mice on the CON diet (<xref rid="nutrients-17-02829-f001" ref-type="fig">Figure 1</xref>I,J). No differences were observed between CON and FOS or CON and TC groups in cortical porosity, but mice consuming the FOS diet had lower porosity (<italic toggle="yes">p</italic> &lt; 0.05) compared to mice consuming the TC diet (<xref rid="app1-nutrients-17-02829" ref-type="app">Supplementary Table S1</xref>).</p></sec><sec id="sec3dot2-nutrients-17-02829"><title>3.2. FOS and TC Effects on IGF-1 and Bone Biomarkers</title><p>After 10 wks of dietary treatment, there were no alterations in serum bone resorption or formation markers, CTX-I (<xref rid="nutrients-17-02829-f002" ref-type="fig">Figure 2</xref>A) and P1NP (<xref rid="nutrients-17-02829-f002" ref-type="fig">Figure 2</xref>B) in response to FOS and TC supplementation. Due to reports that IGF-1 is involved in the gut microbiota&#8217;s influence on bone [<xref rid="B2-nutrients-17-02829" ref-type="bibr">2</xref>], serum IGF-1 and its primary binding protein (i.e., IGFBP-3) were assessed. No effects of dietary treatments on serum IGF-1 were noted (<xref rid="nutrients-17-02829-f002" ref-type="fig">Figure 2</xref>C), but the TC and FOS groups exhibited lower serum IGFBP-3 (<italic toggle="yes">p</italic> &lt; 0.05) compared to the CON group (<xref rid="nutrients-17-02829-f002" ref-type="fig">Figure 2</xref>D). As a result, the ratio of IGF-1 to IGFBP3 tended to be increased (<italic toggle="yes">p</italic> = 0.08) in the TC and FOS treated groups compared to CON, but this response did not reach statistical significance after 10 wks (<xref rid="nutrients-17-02829-f002" ref-type="fig">Figure 2</xref>E).</p></sec><sec id="sec3dot3-nutrients-17-02829"><title>3.3. FOS and TC Shift Gut Microbiota Composition and Increase SCFAs</title><p>We next assessed how the dietary interventions altered the composition of the cecal microbiota. Simpson analysis of alpha diversity revealed that TC consumption increased (<italic toggle="yes">p</italic> &lt; 0.01) alpha diversity compared to FOS and CON treatments (<xref rid="nutrients-17-02829-f003" ref-type="fig">Figure 3</xref>A). FOS treatment showed a trend (<italic toggle="yes">p</italic> = 0.078) toward lower alpha diversity relative to CON (<xref rid="nutrients-17-02829-f003" ref-type="fig">Figure 3</xref>A). Analysis of beta diversity using the Jaccard index revealed a notable separation of diet groups with PERMANOVA showing a significant (<italic toggle="yes">p</italic> &lt; 0.01) &#946;-diversity for each pairwise comparison (<xref rid="nutrients-17-02829-f003" ref-type="fig">Figure 3</xref>B). The relative abundance of two bacterial phyla, Actinobacteriota and Defferibacterota, were affected by dietary treatments, while the most abundant phyla in the mouse, Firmicutes, Bacteroidota, Verrucomicrobiota, Cyanobacteria, and Proteobacteria, were not significantly altered by FOS and TC treatment (<xref rid="nutrients-17-02829-f003" ref-type="fig">Figure 3</xref>C). The abundance of Actinobacteria phyla (<italic toggle="yes">p</italic> = 0.0084) was increased in the FOS group compared to CON, but there were no differences between FOS and TC groups (<xref rid="nutrients-17-02829-f003" ref-type="fig">Figure 3</xref>D). Moreover, the Deferribacterota phylum was reduced (<italic toggle="yes">p</italic> &lt; 0.01) in response to the FOS treatment compared to the CON and TC groups (<xref rid="nutrients-17-02829-f003" ref-type="fig">Figure 3</xref>E). The relative abundance of microbial taxa at the family level was also altered by dietary treatments (<xref rid="nutrients-17-02829-f003" ref-type="fig">Figure 3</xref>F). Diet-induced shifts in several families within the Firmicutes phylum were noted, despite no change in the overall abundance of the phylum. This included an increase in the Clostridia_UCG-014 family (<italic toggle="yes">p</italic> &lt; 0.001) and a decrease in the Peptostreptococcaceae family (<italic toggle="yes">p</italic> &lt; 0.0001) with the FOS and TC diets compared to the CON diet (<xref rid="nutrients-17-02829-f003" ref-type="fig">Figure 3</xref>G,H). Similarly, within Firmicutes, Ruminococcaceae was reduced (<italic toggle="yes">p</italic> &lt; 0.05) by the FOS diet compared to the TC and CON diets (<xref rid="nutrients-17-02829-f003" ref-type="fig">Figure 3</xref>I), and the TC diet resulted in a higher relative abundance of Anaerovoracaceae compared to the FOS group (<xref rid="nutrients-17-02829-f003" ref-type="fig">Figure 3</xref>J). Beyond Firmicutes, the FOS diet also reduced the relative abundance of Deferribacteraceae (<italic toggle="yes">p</italic> &lt; 0.05) compared to the TC and CON groups (<xref rid="nutrients-17-02829-f003" ref-type="fig">Figure 3</xref>K). The relative abundance of top family taxa such as Akkermansiaceca, Bifidobacteriaceae, Lachnospiraceae and Lactobacillaceae were not altered by either FOS or TC treatments in this study. Note that genus results are included in <xref rid="app1-nutrients-17-02829" ref-type="app">Supplementary Table S3</xref>.</p><p>SCFAs are produced from microbial fermentation that are known to impact gut physiology and mineral absorption [<xref rid="B49-nutrients-17-02829" ref-type="bibr">49</xref>,<xref rid="B50-nutrients-17-02829" ref-type="bibr">50</xref>], and also have positive effects on the bone [<xref rid="B51-nutrients-17-02829" ref-type="bibr">51</xref>,<xref rid="B52-nutrients-17-02829" ref-type="bibr">52</xref>]. FOS treatment resulted in a higher concentration of fecal acetic acid (<italic toggle="yes">p</italic> &lt; 0.05) compared to the mice on the CON diet (<xref rid="nutrients-17-02829-f003" ref-type="fig">Figure 3</xref>L). Mice on the FOS and TC dietary treatments had higher concentrations of propionic (<italic toggle="yes">p</italic> &lt; 0.05) and butyric acid (<italic toggle="yes">p</italic> &lt; 0.001) compared to CON, but the increase was greater with the FOS compared to the TC diet (<italic toggle="yes">p</italic> &lt; 0.0001) (<xref rid="nutrients-17-02829-f003" ref-type="fig">Figure 3</xref>M,N). Only the FOS diet increased (<italic toggle="yes">p</italic> &lt; 0.05) the concentration of valeric acid in the feces compared to CON (<xref rid="nutrients-17-02829-f003" ref-type="fig">Figure 3</xref>O).</p></sec><sec id="sec3dot4-nutrients-17-02829"><title>3.4. FOS Enhances Treg Counts in the Ileum</title><p>Although we have previously shown that Tregs are not required for the bone protective effects of TC and FOS in young adult female mice [<xref rid="B24-nutrients-17-02829" ref-type="bibr">24</xref>], it remains important to understand how T cell populations within the intestine (i.e., ileum) and bone marrow are affected by prebiotics due to their role of immune modulation.</p><p>Within the ileum, we found that FOS-treated mice had a greater relative abundance of CD4<sup>+</sup>/CD3<sup>+</sup> cells compared to the TC and CON treatments (<italic toggle="yes">p</italic> &lt; 0.0001) (<xref rid="nutrients-17-02829-f004" ref-type="fig">Figure 4</xref>A). There was no effect of either FOS or TC on the relative abundance of CD4<sup>+</sup>CD25<sup>+</sup>FoxP3<sup>+</sup>, regulatory T cells (Treg) cells (<xref rid="nutrients-17-02829-f004" ref-type="fig">Figure 4</xref>B), but FOS-treated mice exhibited a reduction in the CD4<sup>+</sup>ROR&#947;<sup>+</sup>IL17<sup>+</sup> T helper 17 cells (Th17) cells compared to other dietary treatments (<xref rid="nutrients-17-02829-f004" ref-type="fig">Figure 4</xref>C). When T cells were expressed as absolute counts, the FOS treatment resulted in higher number (<italic toggle="yes">p</italic> &lt; 0.05) of CD3<sup>+</sup> (<xref rid="nutrients-17-02829-f004" ref-type="fig">Figure 4</xref>D) and CD4<sup>+</sup> (<xref rid="nutrients-17-02829-f004" ref-type="fig">Figure 4</xref>E) cells compared to TC and CON treatment. FOS also increased the number of Tregs (<italic toggle="yes">p</italic> &lt; 0.0001) compared to TC and CON (<xref rid="nutrients-17-02829-f004" ref-type="fig">Figure 4</xref>F). There were no differences in the number of Th17 cells across the groups (<xref rid="nutrients-17-02829-f004" ref-type="fig">Figure 4</xref>G). FOS also tended to increase the ratio of Tregs to Th17 cells compared to CON and TC (<italic toggle="yes">p</italic> = 0.055) (<xref rid="nutrients-17-02829-f004" ref-type="fig">Figure 4</xref>H). Within the bone marrow, there were no differences in the relative abundance or absolute counts of CD4<sup>+</sup>CD25<sup>+</sup>FoxP3<sup>+</sup> or CD4<sup>+</sup>ROR&#947;<sup>+</sup>IL17<sup>+</sup> T cell populations with the FOS and TC (<xref rid="app1-nutrients-17-02829" ref-type="app">Supplementary Table S2</xref>).</p></sec><sec id="sec3dot5-nutrients-17-02829"><title>3.5. FOS Enhance Bone Formation and Bone Cell Density</title><p>Although FOS improved both the trabecular and cortical bone compartments and TC enhanced trabecular bone, no significant differences due to the prebiotics were observed in serum bone biomarkers after 10 wks of treatment. This prompted us to conduct an exploratory analysis using static and dynamic bone histomorphometry on a subset of samples (n = 3&#8211;4/group) to gain some insight on the effects of these prebiotics on indices of bone formation and mineralization, as well as osteoblast and osteocyte numbers. Within the trabecular bone, the FOS diet increased the bone formation rate per bone surface (BFR/BS; <italic toggle="yes">p</italic> &lt; 0.05) and mineral apposition rate (MAR; <italic toggle="yes">p</italic> &lt; 0.05) compared to mice on the CON diet (<xref rid="nutrients-17-02829-f005" ref-type="fig">Figure 5</xref>A,B).</p><p>The influence of TC on these parameters compared to CON did not reach the level of statistical significance (BFR/BS <italic toggle="yes">p</italic> = 0.10 and MAR <italic toggle="yes">p</italic> = 0.16). Neither FOS nor TC altered the mineralizing surface MS/BS (<xref rid="nutrients-17-02829-f005" ref-type="fig">Figure 5</xref>C). Within the cortical bone, there were no effects of FOS or TC treatment on the BFR, MS/BS, or MAR on the periosteal or endocortical surfaces. To understand the influence of TC and FOS on bone, we next quantified the osteoblast and osteocyte numbers and density. Von Kossa staining revealed that FOS treatment increased the number of osteoblasts compared to the CON (<xref rid="nutrients-17-02829-f005" ref-type="fig">Figure 5</xref>D). TC treatment resulted in a trend (<italic toggle="yes">p</italic> = 0.07) toward increasing the number of osteoblasts compared to CON, but this response did not reach the level of statistical significance (<xref rid="nutrients-17-02829-f005" ref-type="fig">Figure 5</xref>D). FOS treatment resulted in greater osteoblasts density (<italic toggle="yes">p</italic> &lt; 0.001) than in mice receiving the CON diet, but there were no differences between TC and CON (<xref rid="nutrients-17-02829-f005" ref-type="fig">Figure 5</xref>E). FOS also increased the number (<italic toggle="yes">p</italic> &lt; 0.01) (<xref rid="nutrients-17-02829-f005" ref-type="fig">Figure 5</xref>F) and density of osteocytes (<xref rid="nutrients-17-02829-f005" ref-type="fig">Figure 5</xref>G) within the trabecular bone compared to CON. Similar to what we observed with osteoblasts, TC tended (<italic toggle="yes">p</italic> = 0.09) to increase the osteocyte number, but not the density. Silver nitrate staining was performed to visualize the influence of dietary treatment on the number of osteocyte lacuna and the canalicular system in the trabecular (<xref rid="nutrients-17-02829-f005" ref-type="fig">Figure 5</xref>H) and cortical (<xref rid="nutrients-17-02829-f005" ref-type="fig">Figure 5</xref>I) bone. Representative micrographs from each treatment show that the FOS treated mice had both higher number and density of osteocyte lacunae and canalicular structures compared to TC and CON mice, with TC treated mice having more canalicular structures than CON.</p></sec><sec id="sec3dot6-nutrients-17-02829"><title>3.6. ABX Treatment Alters Bone Phenotype and Influences Gut Production of SCFAs</title><p>To understand how the antibiotic and antifungal cocktail influences bone phenotype, we compared mice on CON diet with antibiotics (+ABX) or without antibiotics (-ABX). Mice receiving the ABX had lower whole-body BMD, BMC, and BMA (<italic toggle="yes">p</italic> &lt; 0.01) (<xref rid="nutrients-17-02829-t001" ref-type="table">Table 1</xref>). Within the trabecular bone of the distal femur metaphysis and vertebra, there was no effect of ABX on BV/TV and TbTh, but there was a higher TbN (<italic toggle="yes">p</italic> &lt; 0.01). ABX treatment reduced TbSp in the vertebrae (<italic toggle="yes">p</italic> &lt; 0.001) and tended to have a similar effect on TbSp within the distal femur metaphysis (<italic toggle="yes">p</italic> = 0.0521), although it did not reach statistical significance. In terms of cortical bone, ABX treatment resulted in lower cortical area (<italic toggle="yes">p</italic> &lt; 0.05), but there were no differences in cortical thickness or porosity between the two groups. The observed changes in serum bone biomarkers with ABX included a reduction in serum CTX-I, while serum P1NP levels remained unchanged. Although ABX treatment tended to reduce serum IGF-I (<italic toggle="yes">p</italic> = 0.06), there was no effect of ABX on serum IGFBP-3 or the ratio IGF-I/IGFBP-3 (<xref rid="nutrients-17-02829-t001" ref-type="table">Table 1</xref>). As expected, ABX treatment resulted in lower fecal concentrations of propionic (<italic toggle="yes">p</italic> &lt; 0.01), <italic toggle="yes">n</italic>-butyric (<italic toggle="yes">p</italic> &lt; 0.05), and <italic toggle="yes">n</italic>-valeric acid (<italic toggle="yes">p</italic> &lt; 0.01) but had no effect on acetic acid (<xref rid="nutrients-17-02829-t001" ref-type="table">Table 1</xref>).</p></sec><sec id="sec3dot7-nutrients-17-02829"><title>3.7. ABX Alters the Effect of Dietary Treatment of TC and FOS</title><p>To understand the role of the gut microbiota in mediating the response observed with TC and FOS, we first sought to confirm if the cocktail suppressed SCFA-producing bacteria and the bacterial load as indicated by gDNA. The concentrations of acetic, propionic, and butyric acids in the TC- and FOS-treated groups were reduced by ABX treatment (<xref rid="nutrients-17-02829-t002" ref-type="table">Table 2</xref>). ABX had a main effect on valeric acid, lowering its concentration when combined with TC and FOS. FOS treatment increased (<italic toggle="yes">p</italic> &lt; 0.01) cecal gDNA compared to TC and CON treatments, and the suppression of this indicator of bacterial load with ABX was less in the FOS compared to the CON and TC groups (<xref rid="nutrients-17-02829-t002" ref-type="table">Table 2</xref>). Fecal gDNA indicated a main effect of diet (<italic toggle="yes">p</italic> &lt; 0.01) with FOS compared to TC and CON. ABX treatment reduced (<italic toggle="yes">p</italic> &lt; 0.0001) gDNA across all groups. In both cecal and fecal contents, FOS + ABX had higher gDNA concentration compared to other ABX-treated groups.</p><p>Next, we evaluated the bone phenotype of mice on the TC and FOS diets with or without ABX. ABX treatment reduced whole body BMD in the CON diet group, but the TC and FOS diets prevented this loss of BMD (<xref rid="nutrients-17-02829-f006" ref-type="fig">Figure 6</xref>A). In the mid-diaphysis of the femur, there was a main effect ABX reducing cortical thickness (<xref rid="nutrients-17-02829-f006" ref-type="fig">Figure 6</xref>B) and cortical area in all dietary groups (<xref rid="nutrients-17-02829-f006" ref-type="fig">Figure 6</xref>C). An unexpected interaction between ABX and diet was observed in trabecular bone in the distal femur metaphysis. Specifically, ABX combined with TC or FOS led to an increase (<italic toggle="yes">p</italic> &lt; 0.05) in trabecular BV/TV compared to their respective non-ABX groups, with the FOS + ABX group showing the greatest increase (<xref rid="nutrients-17-02829-f006" ref-type="fig">Figure 6</xref>D). In terms of other bone morphological parameters within the femur metaphysis, the influence of ABX on TbN followed a similar pattern, but there was no effect on TbTh (<xref rid="nutrients-17-02829-t003" ref-type="table">Table 3</xref>). TbSp was also reduced (<italic toggle="yes">p</italic> &lt; 0.001) in the FOS + ABX and TC + ABX groups. In the vertebral body, there was a main effect of ABX increasing (<italic toggle="yes">p</italic> &lt; 0.05) BV/TV (<xref rid="nutrients-17-02829-f006" ref-type="fig">Figure 6</xref>E) and TbN (<italic toggle="yes">p</italic> &lt; 0.001) in all dietary groups (<xref rid="nutrients-17-02829-t002" ref-type="table">Table 2</xref>). ABX treatment led to reduced TbSp (<italic toggle="yes">p</italic> &lt; 0.0001) across all groups (<xref rid="nutrients-17-02829-t003" ref-type="table">Table 3</xref>).</p></sec></sec><sec sec-type="discussion" id="sec4-nutrients-17-02829"><title>4. Discussion</title><p>Although simple prebiotics like FOS and complex prebiotics such as tart cherry have each been shown to influence the gut&#8211;bone axis, direct comparisons of their effects are lacking, underscoring the rationale for the present study. In this study we investigated how 10 weeks of dietary supplementation with FOS or TC alters gut microbiota composition and the downstream effects on bone homeostasis in young adult mice. We also assessed the effects of these prebiotics on bone when the gut microbiota is suppressed. Our findings show that both the FOS and TC improved bone structural parameters, but the magnitude of the skeletal response was greater with FOS treatment compared to TC. FOS increased whole body BMC and BMD, which coincided with improvements in cortical thickness and cortical area. Trabecular bone within the distal femoral metaphysis and lumbar vertebral body increased with FOS by 60% and 41%, respectively. In contrast, TC consumption did not alter cortical bone in the femur or whole-body BMD or BMC; however, TC did result in a 19% higher trabecular BV/TV within the distal femur and vertebra body (12%). Previous studies have shown that both FOS and TC have osteoprotective properties, but not all studies specify whether short chain FOS was used. Compared to long-chain FOS, short-chain FOS is more rapidly fermented in the proximal colon, resulting in earlier SCFA production [<xref rid="B53-nutrients-17-02829" ref-type="bibr">53</xref>]. In this study, we used short-chain FOS, which has been shown in previous studies to have a pronounced effects on bone in similar aged female C57BL/6 mice and ovariectomized rats [<xref rid="B24-nutrients-17-02829" ref-type="bibr">24</xref>,<xref rid="B54-nutrients-17-02829" ref-type="bibr">54</xref>]. Our lab and others have reported the beneficial effects of TC on bone health in clinical and preclinical studies. Specifically, supplementing the diet with lyophilized TC powder prevented age-related bone loss in female C57BL/6 mice [<xref rid="B27-nutrients-17-02829" ref-type="bibr">27</xref>] and mitigated bone loss in a tumor necrosis factor (TNF)-overexpressing transgenic model of rheumatoid arthritis [<xref rid="B41-nutrients-17-02829" ref-type="bibr">41</xref>]. Moreover, consuming TC juice (2 x 8 fl. oz./d) for 90 d reduced biomarkers of bone resorption in postmenopausal women [<xref rid="B40-nutrients-17-02829" ref-type="bibr">40</xref>]. Although the beneficial effects of the simple prebiotic FOS and complex prebiotic TC on bone health are known, our intent with this study was to better understand the mechanisms that drive protective responses in bone.</p><p>Based on the improvements in bone density and structural parameters, we next investigated the effect of FOS and TC on bone turnover. After 10 wks of treatment, serum biomarkers of bone formation and resorption, PINP and CTX-I, respectively, were not different between treatment groups, despite the notable changes in the bone mass and structure. Previous studies with prebiotics have also shown that improvements in bone microarchitecture occur without corresponding changes in systemic biomarkers [<xref rid="B55-nutrients-17-02829" ref-type="bibr">55</xref>,<xref rid="B56-nutrients-17-02829" ref-type="bibr">56</xref>,<xref rid="B57-nutrients-17-02829" ref-type="bibr">57</xref>]. The gut microbiota has been reported to influence bone through increased serum IGF-1 [<xref rid="B2-nutrients-17-02829" ref-type="bibr">2</xref>], but we observed no differences in serum IGF-1 in this study. We did detect a reduction in serum IGFBP-3 in the FOS and TC groups compared to control, which could indicate an increase in bioavailable IGF-1. However, there were no statistically significant differences between diet groups when IGF-1 was expressed as a ratio of IGFBP-3. Due to the lack of systemic changes in bone turnover markers, we performed static and dynamic bone histomorphometry on a subset of mice to investigate local changes in the bone. Even with this small sample size, we observed that dietary FOS increased the rate of bone formation and mineralization. Similar trends were observed with TC, though these effects did not reach statistical significance. The number and density of both osteoblasts and osteocytes were higher in the FOS-fed animals. Osteoblast and osteocyte number tended to increase with TC, but not density. From a mechanistic standpoint, these results indicate the improved structural properties with FOS were driven by increased osteoblast activity that resulted in greater bone formation as well as bone mineralization rates. TC is likely having similar effects, but the magnitude of the response was not as great. Because the prebiotic components of tart cherry are embedded within a complex matrix that includes other components, it is plausible that their fermentation may be slower and occur lower within the gastrointestinal tract. Similar effects of plant matrices have been observed on fermentation kinetics in in vitro models with chicory [<xref rid="B58-nutrients-17-02829" ref-type="bibr">58</xref>]. Additionally, the increase in osteocyte density in long bones with FOS confirms our previous unanticipated finding of an increase in osteocytes within the vertebrae [<xref rid="B24-nutrients-17-02829" ref-type="bibr">24</xref>]. The implications of these findings as they relate to osteocytes and their role in mechanosensing and age-related bone loss warrant further investigation.</p><p>One of the mechanisms by which prebiotics enhance bone health is through gut microbiota modulation and the subsequent production of xenometabolites [<xref rid="B59-nutrients-17-02829" ref-type="bibr">59</xref>]. In particular, metabolites such as the SCFAs, hippuric acid, and other phenolic acids detected in circulation with prebiotic supplemented diets have been reported to have osteogenic properties in in vitro and in vivo studies [<xref rid="B51-nutrients-17-02829" ref-type="bibr">51</xref>,<xref rid="B60-nutrients-17-02829" ref-type="bibr">60</xref>,<xref rid="B61-nutrients-17-02829" ref-type="bibr">61</xref>]. To investigate how FOS and TC influence the gut microbiota, microbial populations in cecal contents were profiled. &#946;-diversity analysis revealed there was a difference in the composition of the gut microbiota between treatments. Although the most abundant bacterial phyla in the mouse (i.e., Firmicutes, Bacteroidetes, Proteobacteria) were not altered, Actinobacteriota increased with FOS treatment and the less characterized Defferibacterota decreased by the FOS treatment. Families within the Actinobacteria phylum, most especially bifidobacteriaceae, which is commonly used as a probiotic have been positively correlated with BMD [<xref rid="B62-nutrients-17-02829" ref-type="bibr">62</xref>,<xref rid="B63-nutrients-17-02829" ref-type="bibr">63</xref>,<xref rid="B64-nutrients-17-02829" ref-type="bibr">64</xref>]. The abundance of a member of the Clostridia family (i.e., Clostridia_UCG-014), which is known to be SCFA-producing was greater with both the FOS and TC treatment. This coincided with the increased fecal SCFA concentrations (i.e., propionic and butyric acids) observed with the FOS and TC treatment. It is worth noting that fecal acetic and valeric acids were increased in the FOS treatment only. Increased SCFAs with FOS correlated with increased trabecular and cortical bone. While butyric acid has been reported to induce mesenchymal stem cells to differentiate into osteoblast and stimulate bone formation in mice [<xref rid="B65-nutrients-17-02829" ref-type="bibr">65</xref>,<xref rid="B66-nutrients-17-02829" ref-type="bibr">66</xref>], valeric acid has been recently shown to be associated with higher BMD in a population-based study [<xref rid="B67-nutrients-17-02829" ref-type="bibr">67</xref>]. Acetate, propionate, and valeric acid have been reported to promote osteoblast differentiation, although the precise mechanism through which these effects are mediated remains in question [<xref rid="B67-nutrients-17-02829" ref-type="bibr">67</xref>,<xref rid="B68-nutrients-17-02829" ref-type="bibr">68</xref>].</p><p>SCFAs influence bone by modulating the immune system, specifically increasing the Treg/Th17 ratio, which results in a more anti-inflammatory phenotype [<xref rid="B26-nutrients-17-02829" ref-type="bibr">26</xref>]. The effects of SCFAs can act through receptor-mediated pathways such as GPR109A, GPR41 and GPR43 as well as epigenetic changes (i.e., histone deacetylation) [<xref rid="B69-nutrients-17-02829" ref-type="bibr">69</xref>,<xref rid="B70-nutrients-17-02829" ref-type="bibr">70</xref>]. Interestingly, the loss of GPR109A has been shown to impair the anti-inflammatory effects of butyrate [<xref rid="B71-nutrients-17-02829" ref-type="bibr">71</xref>]. FOS and TC treatment increased bacterial load without inducing inflammation, as evidenced by the Treg and Th17 cell populations. TC polyphenols may also act through mechanisms independent of SCFAs. Following absorption and hepatic metabolism, circulating phenolic metabolites such as hippuric acid which is known to act through GPR109A has been shown to improve bone mass [<xref rid="B60-nutrients-17-02829" ref-type="bibr">60</xref>]. These SCFA-independent effects could contribute to the osteoprotective activity of TC as well. Several factors could explain why FOS produced greater skeletal effects than TC. First, the two prebiotics were matched by weight rather than by FOS content, which means the amount of FOS in the TC diet was lower than in the FOS diet. Second, the structural simplicity of FOS allows for rapid fermentation and earlier SCFA release, whereas the prebiotic compounds in TC are embedded within a complex food matrix that may slow fermentation and shift metabolism further along the gut. Third, these differences in substrate composition likely influenced the gut microbial community, leading to distinct SCFA profiles and potentially other metabolites that contribute to divergent skeletal responses. These findings support the idea that dietary interventions with FOS and TC enhance bone health by modulating the gut microbiota to favor the production of metabolites that have positive effects on osteoblasts.</p><p>To determine whether alterations in the gut microbiota and SCFA production are required to mediate the response observed with FOS and TC, we utilized a broad-spectrum antibiotic cocktail known to suppress microbiota in combination with an antifungal to prevent fungal overgrowth [<xref rid="B43-nutrients-17-02829" ref-type="bibr">43</xref>,<xref rid="B44-nutrients-17-02829" ref-type="bibr">44</xref>,<xref rid="B45-nutrients-17-02829" ref-type="bibr">45</xref>]. In mice consuming the control diet, the cocktail reduced cortical bone area but had no effect on trabecular BV/TV in either the distal femur metaphysis or vertebral body. As expected, the addition of the ABX cocktail in mice fed FOS or TC diets resulted in reduced cortical thickness and area. However, in the trabecular bone compartment of the distal femur, an unexpected increase in trabecular BV/TV was observed when the cocktail was combined with the TC or FOS diets. This increase in trabecular bone occurred even though the cocktail reduced fecal SCFA concentrations across all groups, which is consistent with the suppression of SCFA-producing taxa. The trabecular bone response in the femur to the antibiotic/antifungal cocktail suggests that the bone effects at this site are either not mediated by SCFAs alone or that the combination of a prebiotic with this cocktail results in unintended effects on the gut (e.g., altering gut permeability, nutrient absorption or gut-derived metabolites) which acted on the trabecular bone. The cocktail used in this study has been shown to reduce both Gram-negative and -positive bacteria, including the SCFA producing lactobacillus [<xref rid="B72-nutrients-17-02829" ref-type="bibr">72</xref>]. The cecal gDNA levels indicated the bacterial load was suppressed by 90% and 95% in the CON and TC groups treated with the cocktail, respectively, but with the FOS treated mice only 80% suppression was achieved. Unfortunately, characterization of the gut microbiota for the mice receiving the antibiotics was not performed. The effect of the cocktail on trabecular bone was only observed in the FOS and TC groups, raising the question of whether these diets enhance the absorption or bioavailability of some component of the cocktail or nutrients that directly affect bone cellular activity. Many studies utilizing antibiotics to ablate the microbiota have not incorporated antifungal agents to suppress the overgrowth of fungi that can occur when using broad spectrum antibiotics. Although some antifungal agents exhibit histone deacetylase inhibition (HDACi) and HDACi can promote osteoblast differentiation and bone formation [<xref rid="B66-nutrients-17-02829" ref-type="bibr">66</xref>,<xref rid="B73-nutrients-17-02829" ref-type="bibr">73</xref>], we are not aware of reports that amphotericin B acts via this mechanism. It is possible that the antifungal and antibiotics have contributed to the increased trabecular bone independent of microbial suppression. Although the use of broad-spectrum antibiotics to suppress the gut microbiota is a common strategy for studying microbiota-dependent effects, our study points to the fact that this model has notable limitations when combined with prebiotics and may have unintended systemic effects, including altered nutrient metabolism and immune responses [<xref rid="B74-nutrients-17-02829" ref-type="bibr">74</xref>,<xref rid="B75-nutrients-17-02829" ref-type="bibr">75</xref>]. Additionally, this approach does not fully deplete gut microbes and may result in partial suppression or alterations in the microbial communities. As such, the influence of TC and FOS on bone health in the antibiotic cocktails-treated groups should be interpreted with caution. While germ-free models offer the advantage of complete microbiota elimination, they also present limitations such as altered immune and metabolic responses, which complicate interpretation of diet, microbiota, and bone interactions. In contrast, the ABX model used here avoids some of these confounders but introduces other uncertainties, including potential off-target effects on nutrient absorption and gut barrier function that complicates interpretation.</p></sec><sec sec-type="conclusions" id="sec5-nutrients-17-02829"><title>5. Conclusions</title><p>Our findings demonstrate that the beneficial effects of FOS and TC on bone are, in part, mediated by increased bone formation by osteoblasts and bone mineralization. Both prebiotics altered the gut microbiota and increased fecal SCFAs, suggesting a microbiota-associated mechanism. However, because the antibiotic suppression model has the potential to broadly perturb host physiology in addition to depleting the microbiota, it limits our ability to draw causal inferences and leaves the question of whether or not the observed skeletal response to the ABX is microbiota dependent. Future studies using germ-free or fecal transplantation models will be important to more definitively establish the microbiota&#8217;s role.</p><p>Notably, we observed an increase in osteocyte density with FOS, which may be important given the critical role of osteocytes in maintaining bone quality and orchestrating bone remodeling. Enhancing osteocyte populations during youth, as demonstrated in young adult mice in this study, could provide a strategy to strengthen the skeletal foundation early in life and potentially mitigate bone loss with age. Overall, this study indicates that FOS and TC are dietary interventions that warrant further investigation for their potential to support bone health across the lifespan.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-nutrients-17-02829"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.mdpi.com/article/10.3390/nu17172829/s1">https://www.mdpi.com/article/10.3390/nu17172829/s1</uri>, Table S1: Additional Body Composition and Bone Structural Characteristics. Table S2: T-Lymphocyte Absolute Counts and Percentage in Bone Marrow. Table S3: Effects of Prebiotics on the Relative Abundance at the Genus Level.</p><supplementary-material id="nutrients-17-02829-s001" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="nutrients-17-02829-s001.zip" position="float" orientation="portrait"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, J.R., E.A.L. and B.J.S.; Data curation, P.A., J.A.I., S.E.A., B.H., P.I. and B.J.S.; Formal analysis, P.A., J.A.I., S.E.A., B.H., P.I. and T.A.K.; Funding acquisition, A.N.F.V., J.R., E.A.L. and B.J.S.; Methodology, P.A., J.A.I., S.E.A., P.I., A.N.F.V., T.A.K., J.R. and E.A.L.; Project administration, B.J.S.; Writing&#8212;original draft, P.A. and B.J.S.; Writing&#8212;review &amp; editing, P.A., J.A.I., S.E.A., B.H., P.I., A.N.F.V., T.A.K., J.R., E.A.L. and B.J.S. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Oklahoma State University, Institutional Animal Care and Use Committee HS-20-25, 19 May 2020.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Data associated with this manuscript will be made available upon request.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</p></notes><ref-list><title>References</title><ref id="B1-nutrients-17-02829"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sj&#246;gren</surname><given-names>K.</given-names></name><name name-style="western"><surname>Engdahl</surname><given-names>C.</given-names></name><name name-style="western"><surname>Henning</surname><given-names>P.</given-names></name><name name-style="western"><surname>Lerner</surname><given-names>U.H.</given-names></name><name name-style="western"><surname>Tremaroli</surname><given-names>V.</given-names></name><name name-style="western"><surname>Lagerquist</surname><given-names>M.K.</given-names></name><name name-style="western"><surname>B&#228;ckhed</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ohlsson</surname><given-names>C.</given-names></name></person-group><article-title>The gut microbiota regulates bone mass in mice</article-title><source>J. Bone Miner. Res.</source><year>2012</year><volume>27</volume><fpage>1357</fpage><lpage>1367</lpage><pub-id pub-id-type="doi">10.1002/jbmr.1588</pub-id><pub-id pub-id-type="pmid">22407806</pub-id><pub-id pub-id-type="pmcid">PMC3415623</pub-id></element-citation></ref><ref id="B2-nutrients-17-02829"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yan</surname><given-names>J.</given-names></name><name name-style="western"><surname>Herzog</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Tsang</surname><given-names>K.</given-names></name><name name-style="western"><surname>Brennan</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Bower</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Garrett</surname><given-names>W.S.</given-names></name><name name-style="western"><surname>Sartor</surname><given-names>B.R.</given-names></name><name name-style="western"><surname>Aliprantis</surname><given-names>A.O.</given-names></name><name name-style="western"><surname>Charles</surname><given-names>J.F.</given-names></name></person-group><article-title>Gut microbiota induce IGF-1 and promote bone formation and growth</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2016</year><volume>113</volume><fpage>E7554</fpage><lpage>E7563</lpage><pub-id pub-id-type="doi">10.1073/pnas.1607235113</pub-id><pub-id pub-id-type="pmid">27821775</pub-id><pub-id pub-id-type="pmcid">PMC5127374</pub-id></element-citation></ref><ref id="B3-nutrients-17-02829"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>D&#8217;Amelio</surname><given-names>P.</given-names></name><name name-style="western"><surname>Sassi</surname><given-names>F.</given-names></name></person-group><article-title>Gut microbiota, immune system, and bone</article-title><source>Calcif. Tissue Int.</source><year>2018</year><volume>102</volume><fpage>415</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1007/s00223-017-0331-y</pub-id><pub-id pub-id-type="pmid">28965190</pub-id></element-citation></ref><ref id="B4-nutrients-17-02829"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Behera</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ison</surname><given-names>J.</given-names></name><name name-style="western"><surname>Tyagi</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Tyagi</surname><given-names>N.</given-names></name></person-group><article-title>The role of gut microbiota in bone homeostasis</article-title><source>Bone</source><year>2020</year><volume>135</volume><fpage>115317</fpage><pub-id pub-id-type="doi">10.1016/j.bone.2020.115317</pub-id><pub-id pub-id-type="pmid">32169602</pub-id><pub-id pub-id-type="pmcid">PMC8457311</pub-id></element-citation></ref><ref id="B5-nutrients-17-02829"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zaiss</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Jones</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Schett</surname><given-names>G.</given-names></name><name name-style="western"><surname>Pacifici</surname><given-names>R.</given-names></name></person-group><article-title>The gut-bone axis: How bacterial metabolites bridge the distance</article-title><source>J. Clin. Investig.</source><year>2019</year><volume>129</volume><fpage>3018</fpage><lpage>3028</lpage><pub-id pub-id-type="doi">10.1172/JCI128521</pub-id><pub-id pub-id-type="pmid">31305265</pub-id><pub-id pub-id-type="pmcid">PMC6668676</pub-id></element-citation></ref><ref id="B6-nutrients-17-02829"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guss</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Horsfield</surname><given-names>M.W.</given-names></name><name name-style="western"><surname>Fontenele</surname><given-names>F.F.</given-names></name><name name-style="western"><surname>Sandoval</surname><given-names>T.N.</given-names></name><name name-style="western"><surname>Luna</surname><given-names>M.</given-names></name><name name-style="western"><surname>Apoorva</surname><given-names>F.</given-names></name><name name-style="western"><surname>Lima</surname><given-names>S.F.</given-names></name><name name-style="western"><surname>Bicalho</surname><given-names>R.C.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ley</surname><given-names>R.E.</given-names></name></person-group><article-title>Alterations to the gut microbiome impair bone strength and tissue material properties</article-title><source>J. Bone Miner. Res.</source><year>2017</year><volume>32</volume><fpage>1343</fpage><lpage>1353</lpage><pub-id pub-id-type="doi">10.1002/jbmr.3114</pub-id><pub-id pub-id-type="pmid">28244143</pub-id><pub-id pub-id-type="pmcid">PMC5466506</pub-id></element-citation></ref><ref id="B7-nutrients-17-02829"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J.-Y.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pal</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tyagi</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Dar</surname><given-names>H.</given-names></name><name name-style="western"><surname>Adams</surname><given-names>J.</given-names></name><name name-style="western"><surname>Weitzmann</surname><given-names>M.N.</given-names></name><name name-style="western"><surname>Jones</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Pacifici</surname><given-names>R.</given-names></name></person-group><article-title>Parathyroid hormone&#8211;dependent bone formation requires butyrate production by intestinal microbiota</article-title><source>J. Clin. Investig.</source><year>2020</year><volume>130</volume><fpage>1767</fpage><lpage>1781</lpage><pub-id pub-id-type="doi">10.1172/JCI133473</pub-id><pub-id pub-id-type="pmid">31917685</pub-id><pub-id pub-id-type="pmcid">PMC7108906</pub-id></element-citation></ref><ref id="B8-nutrients-17-02829"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>R.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>R.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>X.</given-names></name><name name-style="western"><surname>Gou</surname><given-names>P.</given-names></name><name name-style="western"><surname>Bai</surname><given-names>H.</given-names></name><name name-style="western"><surname>Lei</surname><given-names>P.</given-names></name><name name-style="western"><surname>Xue</surname><given-names>Y.</given-names></name></person-group><article-title>Intermittent parathyroid hormone alters gut microbiota in ovariectomized osteoporotic rats</article-title><source>Orthop. Surg.</source><year>2022</year><volume>14</volume><fpage>2330</fpage><lpage>2338</lpage><pub-id pub-id-type="doi">10.1111/os.13419</pub-id><pub-id pub-id-type="pmid">35946436</pub-id><pub-id pub-id-type="pmcid">PMC9483047</pub-id></element-citation></ref><ref id="B9-nutrients-17-02829"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chargo</surname><given-names>N.J.</given-names></name><name name-style="western"><surname>Neugebauer</surname><given-names>K.</given-names></name><name name-style="western"><surname>Guzior</surname><given-names>D.V.</given-names></name><name name-style="western"><surname>Quinn</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Parameswaran</surname><given-names>N.</given-names></name><name name-style="western"><surname>McCabe</surname><given-names>L.R.</given-names></name></person-group><article-title>Glucocorticoid-induced osteoporosis is prevented by dietary prune in female mice</article-title><source>Front. Cell Dev. Biol.</source><year>2024</year><volume>11</volume><fpage>1324649</fpage><pub-id pub-id-type="doi">10.3389/fcell.2023.1324649</pub-id><pub-id pub-id-type="pmid">38375074</pub-id><pub-id pub-id-type="pmcid">PMC10875082</pub-id></element-citation></ref><ref id="B10-nutrients-17-02829"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schepper</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Collins</surname><given-names>F.</given-names></name><name name-style="western"><surname>Rios-Arce</surname><given-names>N.D.</given-names></name><name name-style="western"><surname>Kang</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>Schaefer</surname><given-names>L.</given-names></name><name name-style="western"><surname>Gardinier</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Raghuvanshi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Quinn</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Britton</surname><given-names>R.</given-names></name><name name-style="western"><surname>Parameswaran</surname><given-names>N.</given-names></name></person-group><article-title>Involvement of the gut microbiota and barrier function in glucocorticoid-induced osteoporosis</article-title><source>J. Bone Miner. Res.</source><year>2020</year><volume>35</volume><fpage>801</fpage><lpage>820</lpage><pub-id pub-id-type="doi">10.1002/jbmr.3947</pub-id><pub-id pub-id-type="pmid">31886921</pub-id></element-citation></ref><ref id="B11-nutrients-17-02829"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rettedal</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Ilesanmi Oyelere</surname><given-names>B.L.</given-names></name><name name-style="western"><surname>Roy</surname><given-names>N.C.</given-names></name><name name-style="western"><surname>Coad</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kruger</surname><given-names>M.C.</given-names></name></person-group><article-title>The gut microbiome is altered in postmenopausal women with osteoporosis and osteopenia</article-title><source>J. Bone Miner. Res. Plus</source><year>2021</year><volume>5</volume><fpage>e10452</fpage><pub-id pub-id-type="doi">10.1002/jbm4.10452</pub-id><pub-id pub-id-type="pmcid">PMC7990138</pub-id><pub-id pub-id-type="pmid">33778322</pub-id></element-citation></ref><ref id="B12-nutrients-17-02829"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>W.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>T.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name></person-group><article-title>Osteoporosis in postmenopausal women is associated with disturbances in gut microbiota and migration of peripheral immune cells</article-title><source>BMC Musculoskelet. Disord.</source><year>2024</year><volume>25</volume><elocation-id>791</elocation-id><pub-id pub-id-type="doi">10.1186/s12891-024-07904-1</pub-id><pub-id pub-id-type="pmid">39375626</pub-id><pub-id pub-id-type="pmcid">PMC11460084</pub-id></element-citation></ref><ref id="B13-nutrients-17-02829"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>D.</given-names></name><name name-style="western"><surname>Cai</surname><given-names>J.</given-names></name><name name-style="western"><surname>Pei</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>F.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>R.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>X.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>T.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name></person-group><article-title>Gut microbial alterations in arginine metabolism determine bone mechanical adaptation</article-title><source>Cell Metab.</source><year>2024</year><volume>36</volume><fpage>1252</fpage><lpage>1268.e1258</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2024.04.004</pub-id><pub-id pub-id-type="pmid">38718794</pub-id></element-citation></ref><ref id="B14-nutrients-17-02829"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gibson</surname><given-names>G.R.</given-names></name><name name-style="western"><surname>Hutkins</surname><given-names>R.</given-names></name><name name-style="western"><surname>Sanders</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Prescott</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Reimer</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Salminen</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Scott</surname><given-names>K.</given-names></name><name name-style="western"><surname>Stanton</surname><given-names>C.</given-names></name><name name-style="western"><surname>Swanson</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Cani</surname><given-names>P.D.</given-names></name></person-group><article-title>Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics</article-title><source>Nat. Rev. Gastroenterol. Hepatol.</source><year>2017</year><volume>14</volume><fpage>491</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1038/nrgastro.2017.75</pub-id><pub-id pub-id-type="pmid">28611480</pub-id></element-citation></ref><ref id="B15-nutrients-17-02829"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davani-Davari</surname><given-names>D.</given-names></name><name name-style="western"><surname>Negahdaripour</surname><given-names>M.</given-names></name><name name-style="western"><surname>Karimzadeh</surname><given-names>I.</given-names></name><name name-style="western"><surname>Seifan</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mohkam</surname><given-names>M.</given-names></name><name name-style="western"><surname>Masoumi</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Berenjian</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ghasemi</surname><given-names>Y.</given-names></name></person-group><article-title>Prebiotics: Definition, types, sources, mechanisms, and clinical applications</article-title><source>Foods</source><year>2019</year><volume>8</volume><elocation-id>92</elocation-id><pub-id pub-id-type="doi">10.3390/foods8030092</pub-id><pub-id pub-id-type="pmid">30857316</pub-id><pub-id pub-id-type="pmcid">PMC6463098</pub-id></element-citation></ref><ref id="B16-nutrients-17-02829"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gibson</surname><given-names>G.R.</given-names></name><name name-style="western"><surname>Scott</surname><given-names>K.P.</given-names></name><name name-style="western"><surname>Rastall</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Tuohy</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Hotchkiss</surname><given-names>A.</given-names></name><name name-style="western"><surname>Dubert-Ferrandon</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gareau</surname><given-names>M.</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>E.F.</given-names></name><name name-style="western"><surname>Saulnier</surname><given-names>D.</given-names></name><name name-style="western"><surname>Loh</surname><given-names>G.</given-names></name></person-group><article-title>Dietary prebiotics: Current status and new definition</article-title><source>Food Sci. Technol. Bull. Funct. Foods</source><year>2010</year><volume>7</volume><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1616/1476-2137.15880</pub-id></element-citation></ref><ref id="B17-nutrients-17-02829"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ganaie</surname><given-names>M.</given-names></name><name name-style="western"><surname>Dehariya</surname><given-names>K.</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>U.</given-names></name></person-group><article-title>Optimization of process parameters of biocatalyst for transformation of sucrose to fructooligosaccharides</article-title><source>Indo Am. J. Pharm. Res.</source><year>2013</year><volume>3</volume><fpage>4138</fpage><lpage>4148</lpage></element-citation></ref><ref id="B18-nutrients-17-02829"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lobo</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Colli</surname><given-names>C.</given-names></name><name name-style="western"><surname>Filisetti</surname><given-names>T.M.</given-names></name></person-group><article-title>Fructooligosaccharides improve bone mass and biomechanical properties in rats</article-title><source>Nutr. Res.</source><year>2006</year><volume>26</volume><fpage>413</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1016/j.nutres.2006.06.019</pub-id></element-citation></ref><ref id="B19-nutrients-17-02829"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takahara</surname><given-names>S.</given-names></name><name name-style="western"><surname>Morohashi</surname><given-names>T.</given-names></name><name name-style="western"><surname>Sano</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ohta</surname><given-names>A.</given-names></name><name name-style="western"><surname>Yamada</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sasa</surname><given-names>R.</given-names></name></person-group><article-title>Fructooligosaccharide consumption enhances femoral bone volume and mineral concentrations in rats</article-title><source>J. Nutr.</source><year>2000</year><volume>130</volume><fpage>1792</fpage><lpage>1795</lpage><pub-id pub-id-type="doi">10.1093/jn/130.7.1792</pub-id><pub-id pub-id-type="pmid">10867052</pub-id></element-citation></ref><ref id="B20-nutrients-17-02829"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ohta</surname><given-names>A.</given-names></name><name name-style="western"><surname>Motohashi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Sakai</surname><given-names>K.</given-names></name><name name-style="western"><surname>Hirayama</surname><given-names>M.</given-names></name><name name-style="western"><surname>Adachi</surname><given-names>T.</given-names></name><name name-style="western"><surname>Sakuma</surname><given-names>K.</given-names></name></person-group><article-title>Dietary fructooligosaccharides increase calcium absorption and levels of mucosal calbindin-D9k in the large intestine of gastrectomized rats</article-title><source>Scand. J. Gastroenterol.</source><year>1998</year><volume>33</volume><fpage>1062</fpage><lpage>1068</lpage><pub-id pub-id-type="pmid">9829361</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/003655298750026769</pub-id></element-citation></ref><ref id="B21-nutrients-17-02829"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wastney</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Zafar</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Weaver</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Martin</surname><given-names>B.R.</given-names></name></person-group><article-title>Nondigestible oligosaccharides increase calcium absorption and suppress bone resorption in ovariectomized rats</article-title><source>J. Nutr.</source><year>2004</year><volume>134</volume><fpage>399</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1093/jn/134.2.399</pub-id><pub-id pub-id-type="pmid">14747679</pub-id></element-citation></ref><ref id="B22-nutrients-17-02829"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abrams</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Griffin</surname><given-names>I.J.</given-names></name><name name-style="western"><surname>Hawthorne</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Gunn</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Darlington</surname><given-names>G.</given-names></name><name name-style="western"><surname>Ellis</surname><given-names>K.J.</given-names></name></person-group><article-title>A combination of prebiotic short-and long-chain inulin-type fructans enhances calcium absorption and bone mineralization in young adolescents</article-title><source>Am. J. Clin. Nutr.</source><year>2005</year><volume>82</volume><fpage>471</fpage><lpage>476</lpage><pub-id pub-id-type="doi">10.1093/ajcn/82.2.471</pub-id><pub-id pub-id-type="pmid">16087995</pub-id></element-citation></ref><ref id="B23-nutrients-17-02829"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Slevin</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Allsopp</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Magee</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Bonham</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>Naughton</surname><given-names>V.R.</given-names></name><name name-style="western"><surname>Strain</surname><given-names>J.</given-names></name><name name-style="western"><surname>Duffy</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Wallace</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Mc Sorley</surname><given-names>E.M.</given-names></name></person-group><article-title>Supplementation with calcium and short-chain fructo-oligosaccharides affects markers of bone turnover but not bone mineral density in postmenopausal women</article-title><source>J. Nutr.</source><year>2014</year><volume>144</volume><fpage>297</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.3945/jn.113.188144</pub-id><pub-id pub-id-type="pmid">24453130</pub-id></element-citation></ref><ref id="B24-nutrients-17-02829"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Islam</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ice</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Alake</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Adedigba</surname><given-names>P.</given-names></name><name name-style="western"><surname>Hatter</surname><given-names>B.</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>K.</given-names></name><name name-style="western"><surname>Clarke</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Ford Versypt</surname><given-names>A.N.</given-names></name><name name-style="western"><surname>Ritchey</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lucas</surname><given-names>E.A.</given-names></name></person-group><article-title>Fructooligosaccharides act on the gut&#8211;bone axis to improve bone independent of Tregs and alter osteocytes in young adult C57BL/6 female mice</article-title><source>JBMR Plus</source><year>2024</year><volume>8</volume><fpage>ziae021</fpage><pub-id pub-id-type="doi">10.1093/jbmrpl/ziae021</pub-id><pub-id pub-id-type="pmid">38562914</pub-id><pub-id pub-id-type="pmcid">PMC10982850</pub-id></element-citation></ref><ref id="B25-nutrients-17-02829"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mao</surname><given-names>B.</given-names></name><name name-style="western"><surname>Gu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>D.</given-names></name><name name-style="western"><surname>Cui</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W.</given-names></name></person-group><article-title>Effects of different doses of fructooligosaccharides (FOS) on the composition of mice fecal microbiota, especially the Bifidobacterium composition</article-title><source>Nutrients</source><year>2018</year><volume>10</volume><elocation-id>1105</elocation-id><pub-id pub-id-type="doi">10.3390/nu10081105</pub-id><pub-id pub-id-type="pmid">30115879</pub-id><pub-id pub-id-type="pmcid">PMC6115998</pub-id></element-citation></ref><ref id="B26-nutrients-17-02829"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mayta-Apaza</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Pottgen</surname><given-names>E.</given-names></name><name name-style="western"><surname>De Bodt</surname><given-names>J.</given-names></name><name name-style="western"><surname>Papp</surname><given-names>N.</given-names></name><name name-style="western"><surname>Marasini</surname><given-names>D.</given-names></name><name name-style="western"><surname>Howard</surname><given-names>L.</given-names></name><name name-style="western"><surname>Abranko</surname><given-names>L.</given-names></name><name name-style="western"><surname>Van de Wiele</surname><given-names>T.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.-O.</given-names></name><name name-style="western"><surname>Carbonero</surname><given-names>F.</given-names></name></person-group><article-title>Impact of tart cherries polyphenols on the human gut microbiota and phenolic metabolites in vitro and in vivo</article-title><source>J. Nutr. Biochem.</source><year>2018</year><volume>59</volume><fpage>160</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2018.04.001</pub-id><pub-id pub-id-type="pmid">30055451</pub-id></element-citation></ref><ref id="B27-nutrients-17-02829"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Crockett</surname><given-names>E.K.</given-names></name><name name-style="western"><surname>Chongwatpol</surname><given-names>P.</given-names></name><name name-style="western"><surname>Graef</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Clarke</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Rendina-Ruedy</surname><given-names>E.</given-names></name><name name-style="western"><surname>Lucas</surname><given-names>E.A.</given-names></name></person-group><article-title>Montmorency tart cherry protects against age-related bone loss in female C57BL/6 mice and demonstrates some anabolic effects</article-title><source>Eur. J. Nutr.</source><year>2019</year><volume>58</volume><fpage>3035</fpage><lpage>3046</lpage><pub-id pub-id-type="doi">10.1007/s00394-018-1848-1</pub-id><pub-id pub-id-type="pmid">30377814</pub-id></element-citation></ref><ref id="B28-nutrients-17-02829"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ou</surname><given-names>B.</given-names></name><name name-style="western"><surname>Bosak</surname><given-names>K.N.</given-names></name><name name-style="western"><surname>Brickner</surname><given-names>P.R.</given-names></name><name name-style="western"><surname>Iezzoni</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Seymour</surname><given-names>E.M.</given-names></name></person-group><article-title>Processed Tart Cherry Products&#8212;Comparative Phytochemical Content, in vitro Antioxidant Capacity and in vitro Anti-inflammatory Activity</article-title><source>J. Food Sci.</source><year>2012</year><volume>77</volume><fpage>H105</fpage><lpage>H112</lpage><pub-id pub-id-type="doi">10.1111/j.1750-3841.2012.02681.x</pub-id><pub-id pub-id-type="pmid">23163942</pub-id></element-citation></ref><ref id="B29-nutrients-17-02829"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chai</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Davis</surname><given-names>K.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zha</surname><given-names>L.</given-names></name><name name-style="western"><surname>Kirschner</surname><given-names>K.F.</given-names></name></person-group><article-title>Effects of tart cherry juice on biomarkers of inflammation and oxidative stress in older adults</article-title><source>Nutrients</source><year>2019</year><volume>11</volume><elocation-id>228</elocation-id><pub-id pub-id-type="doi">10.3390/nu11020228</pub-id><pub-id pub-id-type="pmid">30678193</pub-id><pub-id pub-id-type="pmcid">PMC6413159</pub-id></element-citation></ref><ref id="B30-nutrients-17-02829"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blando</surname><given-names>F.</given-names></name><name name-style="western"><surname>Gerardi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Nicoletti</surname><given-names>I.</given-names></name></person-group><article-title>Sour cherry (Prunus cerasus L) anthocyanins as ingredients for functional foods</article-title><source>BioMed Res. Int.</source><year>2004</year><volume>2004</volume><fpage>253</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1155/S1110724304404136</pub-id><pub-id pub-id-type="pmid">15577186</pub-id><pub-id pub-id-type="pmcid">PMC1082898</pub-id></element-citation></ref><ref id="B31-nutrients-17-02829"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morais</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>de Rosso</surname><given-names>V.V.</given-names></name><name name-style="western"><surname>Estadella</surname><given-names>D.</given-names></name><name name-style="western"><surname>Pisani</surname><given-names>L.P.</given-names></name></person-group><article-title>Anthocyanins as inflammatory modulators and the role of the gut microbiota</article-title><source>J. Nutr. Biochem.</source><year>2016</year><volume>33</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2015.11.008</pub-id><pub-id pub-id-type="pmid">27260462</pub-id></element-citation></ref><ref id="B32-nutrients-17-02829"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jovanovic-Malinovska</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kuzmanova</surname><given-names>S.</given-names></name><name name-style="western"><surname>Winkelhausen</surname><given-names>E.</given-names></name></person-group><article-title>Oligosaccharide profile in fruits and vegetables as sources of prebiotics and functional foods</article-title><source>Int. J. Food Prop.</source><year>2014</year><volume>17</volume><fpage>949</fpage><lpage>965</lpage><pub-id pub-id-type="doi">10.1080/10942912.2012.680221</pub-id></element-citation></ref><ref id="B33-nutrients-17-02829"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaur</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ojo</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>S.Y.</given-names></name><name name-style="western"><surname>Alake</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Pastor</surname><given-names>M.</given-names></name><name name-style="western"><surname>Davila-El Rassi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>D.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Lucas</surname><given-names>E.A.</given-names></name></person-group><article-title>Montmorencytart cherry supplementation improved markers of glucose homeostasis but has modest effects on indicators of gut health in mice fed a Western diet</article-title><source>Nutr. Res.</source><year>2022</year><volume>99</volume><fpage>66</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.nutres.2021.10.003</pub-id><pub-id pub-id-type="pmid">35101747</pub-id></element-citation></ref><ref id="B34-nutrients-17-02829"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verediano</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Stampini Duarte Martino</surname><given-names>H.</given-names></name><name name-style="western"><surname>Dias Paes</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Tako</surname><given-names>E.</given-names></name></person-group><article-title>Effects of anthocyanin on intestinal health: A systematic review</article-title><source>Nutrients</source><year>2021</year><volume>13</volume><elocation-id>1331</elocation-id><pub-id pub-id-type="doi">10.3390/nu13041331</pub-id><pub-id pub-id-type="pmid">33920564</pub-id><pub-id pub-id-type="pmcid">PMC8074038</pub-id></element-citation></ref><ref id="B35-nutrients-17-02829"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bell</surname><given-names>P.</given-names></name><name name-style="western"><surname>McHugh</surname><given-names>M.</given-names></name><name name-style="western"><surname>Stevenson</surname><given-names>E.</given-names></name><name name-style="western"><surname>Howatson</surname><given-names>G.</given-names></name></person-group><article-title>The role of cherries in exercise and health</article-title><source>Scand. J. Med. Sci. Sports</source><year>2014</year><volume>24</volume><fpage>477</fpage><lpage>490</lpage><pub-id pub-id-type="doi">10.1111/sms.12085</pub-id><pub-id pub-id-type="pmid">23710994</pub-id></element-citation></ref><ref id="B36-nutrients-17-02829"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Howatson</surname><given-names>G.</given-names></name><name name-style="western"><surname>Bell</surname><given-names>P.G.</given-names></name><name name-style="western"><surname>Tallent</surname><given-names>J.</given-names></name><name name-style="western"><surname>Middleton</surname><given-names>B.</given-names></name><name name-style="western"><surname>McHugh</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>Ellis</surname><given-names>J.</given-names></name></person-group><article-title>Effect of tart cherry juice (<italic toggle="yes">Prunus cerasus</italic>) on melatonin levels and enhanced sleep quality</article-title><source>Eur. J. Nutr.</source><year>2012</year><volume>51</volume><fpage>909</fpage><lpage>916</lpage><pub-id pub-id-type="doi">10.1007/s00394-011-0263-7</pub-id><pub-id pub-id-type="pmid">22038497</pub-id></element-citation></ref><ref id="B37-nutrients-17-02829"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Keane</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>George</surname><given-names>T.W.</given-names></name><name name-style="western"><surname>Constantinou</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Brown</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Clifford</surname><given-names>T.</given-names></name><name name-style="western"><surname>Howatson</surname><given-names>G.</given-names></name></person-group><article-title>Effects of Montmorency tart cherry (<italic toggle="yes">Prunus cerasus</italic> L.) consumption on vascular function in men with early hypertension</article-title><source>Am. J. Clin. Nutr.</source><year>2016</year><volume>103</volume><fpage>1531</fpage><lpage>1539</lpage><pub-id pub-id-type="doi">10.3945/ajcn.115.123869</pub-id><pub-id pub-id-type="pmid">27146650</pub-id></element-citation></ref><ref id="B38-nutrients-17-02829"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schumacher</surname><given-names>H.</given-names></name><name name-style="western"><surname>Pullman-Mooar</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>S.</given-names></name><name name-style="western"><surname>Dinnella</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>R.</given-names></name><name name-style="western"><surname>McHugh</surname><given-names>M.</given-names></name></person-group><article-title>Randomized double-blind crossover study of the efficacy of a tart cherry juice blend in treatment of osteoarthritis (OA) of the knee</article-title><source>Osteoarthr. Cartil.</source><year>2013</year><volume>21</volume><fpage>1035</fpage><lpage>1041</lpage><pub-id pub-id-type="doi">10.1016/j.joca.2013.05.009</pub-id><pub-id pub-id-type="pmid">23727631</pub-id></element-citation></ref><ref id="B39-nutrients-17-02829"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Howatson</surname><given-names>G.</given-names></name><name name-style="western"><surname>McHugh</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>Hill</surname><given-names>J.</given-names></name><name name-style="western"><surname>Brouner</surname><given-names>J.</given-names></name><name name-style="western"><surname>Jewell</surname><given-names>A.</given-names></name><name name-style="western"><surname>Van Someren</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Shave</surname><given-names>R.</given-names></name><name name-style="western"><surname>Howatson</surname><given-names>S.</given-names></name></person-group><article-title>Influence of tart cherry juice on indices of recovery following marathon running</article-title><source>Scand. J. Med. Sci. Sports</source><year>2010</year><volume>20</volume><fpage>843</fpage><lpage>852</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0838.2009.01005.x</pub-id><pub-id pub-id-type="pmid">19883392</pub-id></element-citation></ref><ref id="B40-nutrients-17-02829"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dodier</surname><given-names>T.</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>K.L.</given-names></name><name name-style="western"><surname>Bothwell</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hermann</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lucas</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>B.J.</given-names></name></person-group><article-title>US Montmorency tart cherry juice decreases bone resorption in women aged 65&#8211;80 years</article-title><source>Nutrients</source><year>2021</year><volume>13</volume><elocation-id>544</elocation-id><pub-id pub-id-type="doi">10.3390/nu13020544</pub-id><pub-id pub-id-type="pmid">33562341</pub-id><pub-id pub-id-type="pmcid">PMC7914470</pub-id></element-citation></ref><ref id="B41-nutrients-17-02829"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moon</surname><given-names>N.</given-names></name><name name-style="western"><surname>Effiong</surname><given-names>L.</given-names></name><name name-style="western"><surname>Song</surname><given-names>L.</given-names></name><name name-style="western"><surname>Gardner</surname><given-names>T.R.</given-names></name><name name-style="western"><surname>Soung</surname><given-names>D.Y.</given-names></name></person-group><article-title>Tart cherry prevents bone loss through inhibition of RANKL in TNF-overexpressing mice</article-title><source>Nutrients</source><year>2018</year><volume>11</volume><elocation-id>63</elocation-id><pub-id pub-id-type="doi">10.3390/nu11010063</pub-id><pub-id pub-id-type="pmid">30597968</pub-id><pub-id pub-id-type="pmcid">PMC6356454</pub-id></element-citation></ref><ref id="B42-nutrients-17-02829"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reeves</surname><given-names>P.G.</given-names></name><name name-style="western"><surname>Nielsen</surname><given-names>F.H.</given-names></name><name name-style="western"><surname>Fahey</surname><given-names>G.C.</given-names><suffix>Jr.</suffix></name></person-group><article-title>AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet</article-title><source>J. Nutr.</source><year>1993</year><volume>123</volume><fpage>1939</fpage><lpage>1951</lpage><pub-id pub-id-type="doi">10.1093/jn/123.11.1939</pub-id><pub-id pub-id-type="pmid">8229312</pub-id></element-citation></ref><ref id="B43-nutrients-17-02829"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Malik Tyagi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.-Y.</given-names></name><name name-style="western"><surname>Adams</surname><given-names>J.</given-names></name><name name-style="western"><surname>Denning</surname><given-names>T.L.</given-names></name><name name-style="western"><surname>Weitzmann</surname><given-names>M.N.</given-names></name><name name-style="western"><surname>Jones</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Pacifici</surname><given-names>R.</given-names></name></person-group><article-title>PTH induces bone loss via microbial-dependent expansion of intestinal TNF+ T cells and Th17 cells</article-title><source>Nat. Commun.</source><year>2020</year><volume>11</volume><fpage>468</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-14148-4</pub-id><pub-id pub-id-type="pmid">31980603</pub-id><pub-id pub-id-type="pmcid">PMC6981196</pub-id></element-citation></ref><ref id="B44-nutrients-17-02829"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rakoff-Nahoum</surname><given-names>S.</given-names></name><name name-style="western"><surname>Paglino</surname><given-names>J.</given-names></name><name name-style="western"><surname>Eslami-Varzaneh</surname><given-names>F.</given-names></name><name name-style="western"><surname>Edberg</surname><given-names>S.</given-names></name><name name-style="western"><surname>Medzhitov</surname><given-names>R.</given-names></name></person-group><article-title>Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis</article-title><source>Cell</source><year>2004</year><volume>118</volume><fpage>229</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2004.07.002</pub-id><pub-id pub-id-type="pmid">15260992</pub-id></element-citation></ref><ref id="B45-nutrients-17-02829"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erdogan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Rao</surname><given-names>S.S.</given-names></name></person-group><article-title>Small intestinal fungal overgrowth</article-title><source>Curr. Gastroenterol. Rep.</source><year>2015</year><volume>17</volume><fpage>16</fpage><pub-id pub-id-type="doi">10.1007/s11894-015-0436-2</pub-id><pub-id pub-id-type="pmid">25786900</pub-id></element-citation></ref><ref id="B46-nutrients-17-02829"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scortichini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Boarelli</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Silvi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fiorini</surname><given-names>D.</given-names></name></person-group><article-title>Development and validation of a GC-FID method for the analysis of short chain fatty acids in rat and human faeces and in fermentation fluids</article-title><source>J. Chromatogr. B</source><year>2020</year><volume>1143</volume><fpage>121972</fpage><pub-id pub-id-type="doi">10.1016/j.jchromb.2020.121972</pub-id><pub-id pub-id-type="pmid">32193004</pub-id></element-citation></ref><ref id="B47-nutrients-17-02829"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferrand</surname><given-names>J.</given-names></name><name name-style="western"><surname>Patron</surname><given-names>K.</given-names></name><name name-style="western"><surname>Legrand-Frossi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Frippiat</surname><given-names>J.-P.</given-names></name><name name-style="western"><surname>Merlin</surname><given-names>C.</given-names></name><name name-style="western"><surname>Alauzet</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lozniewski</surname><given-names>A.</given-names></name></person-group><article-title>Comparison of seven methods for extraction of bacterial DNA from fecal and cecal samples of mice</article-title><source>J. Microbiol. Methods</source><year>2014</year><volume>105</volume><fpage>180</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1016/j.mimet.2014.07.029</pub-id><pub-id pub-id-type="pmid">25093756</pub-id></element-citation></ref><ref id="B48-nutrients-17-02829"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dempster</surname><given-names>D.W.</given-names></name><name name-style="western"><surname>Compston</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Drezner</surname><given-names>M.K.</given-names></name><name name-style="western"><surname>Glorieux</surname><given-names>F.H.</given-names></name><name name-style="western"><surname>Kanis</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Malluche</surname><given-names>H.</given-names></name><name name-style="western"><surname>Meunier</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Ott</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Recker</surname><given-names>R.R.</given-names></name><name name-style="western"><surname>Parfitt</surname><given-names>A.M.</given-names></name></person-group><article-title>Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee</article-title><source>J. Bone Miner. Res.</source><year>2013</year><volume>28</volume><fpage>2</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1002/jbmr.1805</pub-id><pub-id pub-id-type="pmid">23197339</pub-id><pub-id pub-id-type="pmcid">PMC3672237</pub-id></element-citation></ref><ref id="B49-nutrients-17-02829"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S.-e.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>H.-X.</given-names></name></person-group><article-title>Fructo-oligosaccharides enhance the mineral absorption and counteract the adverse effects of phytic acid in mice</article-title><source>Nutrition</source><year>2010</year><volume>26</volume><fpage>305</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.1016/j.nut.2009.04.014</pub-id><pub-id pub-id-type="pmid">19665870</pub-id></element-citation></ref><ref id="B50-nutrients-17-02829"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Priyadarshini</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kotlo</surname><given-names>K.U.</given-names></name><name name-style="western"><surname>Dudeja</surname><given-names>P.K.</given-names></name><name name-style="western"><surname>Layden</surname><given-names>B.T.</given-names></name></person-group><article-title>Role of short chain fatty acid receptors in intestinal physiology and pathophysiology</article-title><source>Compr. Physiol.</source><year>2018</year><volume>8</volume><fpage>1091</fpage><pub-id pub-id-type="doi">10.1002/j.2040-4603.2018.tb00038.x</pub-id><pub-id pub-id-type="pmid">29978895</pub-id><pub-id pub-id-type="pmcid">PMC6058973</pub-id></element-citation></ref><ref id="B51-nutrients-17-02829"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lucas</surname><given-names>S.</given-names></name><name name-style="western"><surname>Omata</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hofmann</surname><given-names>J.</given-names></name><name name-style="western"><surname>B&#246;ttcher</surname><given-names>M.</given-names></name><name name-style="western"><surname>Iljazovic</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sarter</surname><given-names>K.</given-names></name><name name-style="western"><surname>Albrecht</surname><given-names>O.</given-names></name><name name-style="western"><surname>Schulz</surname><given-names>O.</given-names></name><name name-style="western"><surname>Krishnacoumar</surname><given-names>B.</given-names></name><name name-style="western"><surname>Kr&#246;nke</surname><given-names>G.</given-names></name></person-group><article-title>Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss</article-title><source>Nat. Commun.</source><year>2018</year><volume>9</volume><fpage>55</fpage><pub-id pub-id-type="doi">10.1038/s41467-017-02490-4</pub-id><pub-id pub-id-type="pmid">29302038</pub-id><pub-id pub-id-type="pmcid">PMC5754356</pub-id></element-citation></ref><ref id="B52-nutrients-17-02829"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montalvany-Antonucci</surname><given-names>C.</given-names></name><name name-style="western"><surname>Duffles</surname><given-names>L.</given-names></name><name name-style="western"><surname>De Arruda</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zicker</surname><given-names>M.</given-names></name><name name-style="western"><surname>De Oliveira</surname><given-names>S.</given-names></name><name name-style="western"><surname>Macari</surname><given-names>S.</given-names></name><name name-style="western"><surname>Garlet</surname><given-names>G.P.</given-names></name><name name-style="western"><surname>Madeira</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fukada</surname><given-names>S.Y.</given-names></name><name name-style="western"><surname>Andrade</surname><given-names>I.</given-names><suffix>Jr.</suffix></name></person-group><article-title>Short-chain fatty acids and FFAR2 as suppressors of bone resorption</article-title><source>Bone</source><year>2019</year><volume>125</volume><fpage>112</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1016/j.bone.2019.05.016</pub-id><pub-id pub-id-type="pmid">31100533</pub-id></element-citation></ref><ref id="B53-nutrients-17-02829"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stewart</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Timm</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Slavin</surname><given-names>J.L.</given-names></name></person-group><article-title>Fructooligosaccharides exhibit more rapid fermentation than long-chain inulin in an in vitro fermentation system</article-title><source>Nutr. Res.</source><year>2008</year><volume>28</volume><fpage>329</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1016/j.nutres.2008.02.014</pub-id><pub-id pub-id-type="pmid">19083428</pub-id></element-citation></ref><ref id="B54-nutrients-17-02829"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Porwal</surname><given-names>K.</given-names></name><name name-style="western"><surname>Pal</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kulkarni</surname><given-names>C.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>P.</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>S.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>P.</given-names></name><name name-style="western"><surname>Prajapati</surname><given-names>G.</given-names></name><name name-style="western"><surname>Gayen</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Ampapathi</surname><given-names>R.S.</given-names></name><name name-style="western"><surname>Mullick</surname><given-names>A.</given-names></name></person-group><article-title>A prebiotic, short-chain fructo-oligosaccharides promotes peak bone mass and maintains bone mass in ovariectomized rats by an osteogenic mechanism</article-title><source>Biomed. Pharmacother.</source><year>2020</year><volume>129</volume><elocation-id>110448</elocation-id><pub-id pub-id-type="doi">10.1016/j.biopha.2020.110448</pub-id><pub-id pub-id-type="pmid">32776872</pub-id></element-citation></ref><ref id="B55-nutrients-17-02829"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Bu</surname><given-names>S.Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Rendina</surname><given-names>E.</given-names></name><name name-style="western"><surname>Lim</surname><given-names>Y.F.</given-names></name><name name-style="western"><surname>Marlow</surname><given-names>D.</given-names></name><name name-style="western"><surname>Clarke</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Cullen</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Lucas</surname><given-names>E.A.</given-names></name></person-group><article-title>A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat</article-title><source>Bone</source><year>2014</year><volume>58</volume><fpage>151</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1016/j.bone.2013.10.005</pub-id><pub-id pub-id-type="pmid">24125756</pub-id></element-citation></ref><ref id="B56-nutrients-17-02829"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Hatter</surname><given-names>B.</given-names></name><name name-style="western"><surname>Washburn</surname><given-names>K.</given-names></name><name name-style="western"><surname>Graef-Downard</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ojo</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>El-Rassi</surname><given-names>G.D.</given-names></name><name name-style="western"><surname>Cichewicz</surname><given-names>R.H.</given-names></name><name name-style="western"><surname>Payton</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lucas</surname><given-names>E.A.</given-names></name></person-group><article-title>Dried plum&#8217;s polyphenolic compounds and carbohydrates contribute to its osteoprotective effects and exhibit prebiotic activity in estrogen deficient C57bl/6 mice</article-title><source>Nutrients</source><year>2022</year><volume>14</volume><elocation-id>1685</elocation-id><pub-id pub-id-type="doi">10.3390/nu14091685</pub-id><pub-id pub-id-type="pmid">35565653</pub-id><pub-id pub-id-type="pmcid">PMC9102795</pub-id></element-citation></ref><ref id="B57-nutrients-17-02829"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Halloran</surname><given-names>B.P.</given-names></name><name name-style="western"><surname>Wronski</surname><given-names>T.J.</given-names></name><name name-style="western"><surname>VonHerzen</surname><given-names>D.C.</given-names></name><name name-style="western"><surname>Chu</surname><given-names>V.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>X.</given-names></name><name name-style="western"><surname>Pingel</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Williams</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>B.J.</given-names></name></person-group><article-title>Dietary dried plum increases bone mass in adult and aged male mice</article-title><source>J. Nutr.</source><year>2010</year><volume>140</volume><fpage>1781</fpage><lpage>1787</lpage><pub-id pub-id-type="doi">10.3945/jn.110.124198</pub-id><pub-id pub-id-type="pmid">20739449</pub-id></element-citation></ref><ref id="B58-nutrients-17-02829"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Puhlmann</surname><given-names>M.-L.</given-names></name><name name-style="western"><surname>van de Rakt</surname><given-names>E.</given-names></name><name name-style="western"><surname>Kerezoudi</surname><given-names>E.N.</given-names></name><name name-style="western"><surname>Rangel</surname><given-names>I.</given-names></name><name name-style="western"><surname>Brummer</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Smidt</surname><given-names>H.</given-names></name><name name-style="western"><surname>Kaper</surname><given-names>F.S.</given-names></name><name name-style="western"><surname>de Vos</surname><given-names>W.M.</given-names></name></person-group><article-title>Analysis of the fermentation kinetics and gut microbiota modulatory effect of dried chicory root reveals the impact of the plant-cell matrix rationalizing its conversion in the distal colon</article-title><source>Microbiome Res. Rep.</source><year>2024</year><volume>3</volume><fpage>28</fpage><pub-id pub-id-type="doi">10.20517/mrr.2024.04</pub-id><pub-id pub-id-type="pmid">39421250</pub-id><pub-id pub-id-type="pmcid">PMC11485554</pub-id></element-citation></ref><ref id="B59-nutrients-17-02829"><label>59.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Whisner</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Weaver</surname><given-names>C.M.</given-names></name></person-group><article-title>Prebiotics and bone</article-title><source>Understanding the Gut-Bone Signaling Axis: Mechanisms and Therapeutic Implications</source><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2017</year><fpage>201</fpage><lpage>224</lpage></element-citation></ref><ref id="B60-nutrients-17-02829"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>J.-R.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wankhade</surname><given-names>U.D.</given-names></name><name name-style="western"><surname>Chintapalli</surname><given-names>S.V.</given-names></name><name name-style="western"><surname>Li</surname><given-names>C.</given-names></name><name name-style="western"><surname>Gai</surname><given-names>D.</given-names></name><name name-style="western"><surname>Shankar</surname><given-names>K.</given-names></name><name name-style="western"><surname>Zhan</surname><given-names>F.</given-names></name><name name-style="western"><surname>Lazarenko</surname><given-names>O.P.</given-names></name></person-group><article-title>GPR109A mediates the effects of hippuric acid on regulating osteoclastogenesis and bone resorption in mice</article-title><source>Commun. Biol.</source><year>2021</year><volume>4</volume><fpage>53</fpage><pub-id pub-id-type="doi">10.1038/s42003-020-01564-2</pub-id><pub-id pub-id-type="pmid">33420329</pub-id><pub-id pub-id-type="pmcid">PMC7794563</pub-id></element-citation></ref><ref id="B61-nutrients-17-02829"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>H.</given-names></name><name name-style="western"><surname>Lazarenko</surname><given-names>O.P.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J.R.</given-names></name></person-group><article-title>Hippuric acid and 3-(3-hydroxyphenyl) propionic acid inhibit murine osteoclastogenesis through RANKL-RANK independent pathway</article-title><source>J. Cell. Physiol.</source><year>2020</year><volume>235</volume><fpage>599</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1002/jcp.28998</pub-id><pub-id pub-id-type="pmid">31271661</pub-id><pub-id pub-id-type="pmcid">PMC6852477</pub-id></element-citation></ref><ref id="B62-nutrients-17-02829"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parvaneh</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ebrahimi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sabran</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Karimi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Hwei</surname><given-names>A.N.M.</given-names></name><name name-style="western"><surname>Abdul-Majeed</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Ibrahim</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Jamaluddin</surname><given-names>R.</given-names></name></person-group><article-title>Probiotics (Bifidobacterium longum) increase bone mass density and upregulate Sparc and Bmp-2 genes in rats with bone loss resulting from ovariectomy</article-title><source>BioMed Res. Int.</source><year>2015</year><volume>2015</volume><elocation-id>897639</elocation-id><pub-id pub-id-type="doi">10.1155/2015/897639</pub-id><pub-id pub-id-type="pmid">26366421</pub-id><pub-id pub-id-type="pmcid">PMC4558422</pub-id></element-citation></ref><ref id="B63-nutrients-17-02829"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McCabe</surname><given-names>L.R.</given-names></name><name name-style="western"><surname>Irwin</surname><given-names>R.</given-names></name><name name-style="western"><surname>Tekalur</surname><given-names>A.</given-names></name><name name-style="western"><surname>Evans</surname><given-names>C.</given-names></name><name name-style="western"><surname>Schepper</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Parameswaran</surname><given-names>N.</given-names></name><name name-style="western"><surname>Ciancio</surname><given-names>M.</given-names></name></person-group><article-title>Exercise prevents high fat diet-induced bone loss, marrow adiposity and dysbiosis in male mice</article-title><source>Bone</source><year>2019</year><volume>118</volume><fpage>20</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.bone.2018.03.024</pub-id><pub-id pub-id-type="pmid">29604350</pub-id><pub-id pub-id-type="pmcid">PMC6163087</pub-id></element-citation></ref><ref id="B64-nutrients-17-02829"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wallimann</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hildebrand</surname><given-names>M.</given-names></name><name name-style="western"><surname>Groeger</surname><given-names>D.</given-names></name><name name-style="western"><surname>Stanic</surname><given-names>B.</given-names></name><name name-style="western"><surname>Akdis</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Zeiter</surname><given-names>S.</given-names></name><name name-style="western"><surname>Richards</surname><given-names>R.G.</given-names></name><name name-style="western"><surname>Moriarty</surname><given-names>T.F.</given-names></name><name name-style="western"><surname>O&#8217;Mahony</surname><given-names>L.</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>K.</given-names></name></person-group><article-title>An exopolysaccharide produced by Bifidobacterium longum 35624&#174; inhibits osteoclast formation via a TLR2-dependent mechanism</article-title><source>Calcif. Tissue Int.</source><year>2021</year><volume>108</volume><fpage>654</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1007/s00223-020-00790-4</pub-id><pub-id pub-id-type="pmid">33388801</pub-id></element-citation></ref><ref id="B65-nutrients-17-02829"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tyagi</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Darby</surname><given-names>T.M.</given-names></name><name name-style="western"><surname>Vaccaro</surname><given-names>C.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.-Y.</given-names></name><name name-style="western"><surname>Owens</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>E.</given-names></name><name name-style="western"><surname>Adams</surname><given-names>J.</given-names></name><name name-style="western"><surname>Weitzmann</surname><given-names>M.N.</given-names></name><name name-style="western"><surname>Jones</surname><given-names>R.M.</given-names></name></person-group><article-title>The microbial metabolite butyrate stimulates bone formation via T regulatory cell-mediated regulation of WNT10B expression</article-title><source>Immunity</source><year>2018</year><volume>49</volume><fpage>1116</fpage><lpage>1131.e7</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2018.10.013</pub-id><pub-id pub-id-type="pmid">30446387</pub-id><pub-id pub-id-type="pmcid">PMC6345170</pub-id></element-citation></ref><ref id="B66-nutrients-17-02829"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>T.-H.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W.-M.</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>K.-H.</given-names></name><name name-style="western"><surname>Kuo</surname><given-names>C.-D.</given-names></name><name name-style="western"><surname>Hung</surname><given-names>S.-C.</given-names></name></person-group><article-title>Sodium butyrate activates ERK to regulate differentiation of mesenchymal stem cells</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2007</year><volume>355</volume><fpage>913</fpage><lpage>918</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2007.02.057</pub-id><pub-id pub-id-type="pmid">17331472</pub-id></element-citation></ref><ref id="B67-nutrients-17-02829"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>X.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>H.-M.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H.-M.</given-names></name><name name-style="western"><surname>Lv</surname><given-names>W.-Q.</given-names></name><name name-style="western"><surname>Greenbaum</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gong</surname><given-names>R.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.-C.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>C.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X.-J.</given-names></name></person-group><article-title>Gut microbiota impacts bone via Bacteroides vulgatus-valeric acid-related pathways</article-title><source>Nat. Commun.</source><year>2023</year><volume>14</volume><fpage>6853</fpage><pub-id pub-id-type="doi">10.1038/s41467-023-42005-y</pub-id><pub-id pub-id-type="pmid">37891329</pub-id><pub-id pub-id-type="pmcid">PMC10611739</pub-id></element-citation></ref><ref id="B68-nutrients-17-02829"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kondo</surname><given-names>T.</given-names></name><name name-style="western"><surname>Chiba</surname><given-names>T.</given-names></name><name name-style="western"><surname>Tousen</surname><given-names>Y.</given-names></name></person-group><article-title>Short-chain fatty acids, acetate and propionate, directly upregulate osteoblastic differentiation</article-title><source>Int. J. Food Sci. Nutr.</source><year>2022</year><volume>73</volume><fpage>800</fpage><lpage>808</lpage><pub-id pub-id-type="doi">10.1080/09637486.2022.2078285</pub-id><pub-id pub-id-type="pmid">35616294</pub-id></element-citation></ref><ref id="B69-nutrients-17-02829"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Behler-Janbeck</surname><given-names>F.</given-names></name><name name-style="western"><surname>Baranowsky</surname><given-names>A.</given-names></name><name name-style="western"><surname>Yorgan</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Jaeckstein</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Worthmann</surname><given-names>A.</given-names></name><name name-style="western"><surname>Fuh</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Gunasekaran</surname><given-names>K.</given-names></name><name name-style="western"><surname>Tiegs</surname><given-names>G.</given-names></name><name name-style="western"><surname>Amling</surname><given-names>M.</given-names></name><name name-style="western"><surname>Schinke</surname><given-names>T.</given-names></name></person-group><article-title>The short-chain fatty acid receptors Gpr41/43 regulate bone mass by promoting adipogenic differentiation of mesenchymal stem cells</article-title><source>Front. Endocrinol.</source><year>2024</year><volume>15</volume><fpage>1392418</fpage><pub-id pub-id-type="doi">10.3389/fendo.2024.1392418</pub-id><pub-id pub-id-type="pmcid">PMC11446854</pub-id><pub-id pub-id-type="pmid">39363899</pub-id></element-citation></ref><ref id="B70-nutrients-17-02829"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Modoux</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rolhion</surname><given-names>N.</given-names></name><name name-style="western"><surname>Lefevre</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Oeuvray</surname><given-names>C.</given-names></name><name name-style="western"><surname>N&#225;dvorn&#237;k</surname><given-names>P.</given-names></name><name name-style="western"><surname>Illes</surname><given-names>P.</given-names></name><name name-style="western"><surname>Emond</surname><given-names>P.</given-names></name><name name-style="western"><surname>Parc</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Mani</surname><given-names>S.</given-names></name><name name-style="western"><surname>Dvorak</surname><given-names>Z.</given-names></name></person-group><article-title>Butyrate acts through HDAC inhibition to enhance aryl hydrocarbon receptor activation by gut microbiota-derived ligands</article-title><source>Gut Microbes</source><year>2022</year><volume>14</volume><fpage>2105637</fpage><pub-id pub-id-type="doi">10.1080/19490976.2022.2105637</pub-id><pub-id pub-id-type="pmid">35895845</pub-id><pub-id pub-id-type="pmcid">PMC9336500</pub-id></element-citation></ref><ref id="B71-nutrients-17-02829"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>N.</given-names></name><name name-style="western"><surname>Gurav</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sivaprakasam</surname><given-names>S.</given-names></name><name name-style="western"><surname>Brady</surname><given-names>E.</given-names></name><name name-style="western"><surname>Padia</surname><given-names>R.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Thangaraju</surname><given-names>M.</given-names></name><name name-style="western"><surname>Prasad</surname><given-names>P.D.</given-names></name><name name-style="western"><surname>Manicassamy</surname><given-names>S.</given-names></name><name name-style="western"><surname>Munn</surname><given-names>D.H.</given-names></name></person-group><article-title>Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis</article-title><source>Immunity</source><year>2014</year><volume>40</volume><fpage>128</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2013.12.007</pub-id><pub-id pub-id-type="pmid">24412617</pub-id><pub-id pub-id-type="pmcid">PMC4305274</pub-id></element-citation></ref><ref id="B72-nutrients-17-02829"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>S.</given-names></name><name name-style="western"><surname>Huo</surname><given-names>F.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H.</given-names></name></person-group><article-title>Effects of four antibiotics on the diversity of the intestinal microbiota</article-title><source>Microbiol. Spectr.</source><year>2022</year><volume>10</volume><fpage>e01904</fpage><lpage>e01921</lpage><pub-id pub-id-type="doi">10.1128/spectrum.01904-21</pub-id><pub-id pub-id-type="pmid">35311555</pub-id><pub-id pub-id-type="pmcid">PMC9045271</pub-id></element-citation></ref><ref id="B73-nutrients-17-02829"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Dai</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bi</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Ao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>C.</given-names></name></person-group><article-title>Histone deacetylase inhibitor sodium butyrate promotes the osteogenic differentiation of rat adipose-derived stem cells</article-title><source>Dev. Growth Differ.</source><year>2014</year><volume>56</volume><fpage>206</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1111/dgd.12119</pub-id><pub-id pub-id-type="pmid">24494796</pub-id></element-citation></ref><ref id="B74-nutrients-17-02829"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pusceddu</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Stokes</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gareau</surname><given-names>M.G.</given-names></name><name name-style="western"><surname>Genetos</surname><given-names>D.C.</given-names></name></person-group><article-title>Sexually dimorphic influence of neonatal antibiotics on bone</article-title><source>J. Orthop. Res.</source><year>2019</year><volume>37</volume><fpage>2122</fpage><lpage>2129</lpage><pub-id pub-id-type="doi">10.1002/jor.24396</pub-id><pub-id pub-id-type="pmid">31228216</pub-id><pub-id pub-id-type="pmcid">PMC6886746</pub-id></element-citation></ref><ref id="B75-nutrients-17-02829"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>W.</given-names></name></person-group><article-title>Antibiotic effects on gut microbiota, metabolism, and beyond</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2019</year><volume>103</volume><fpage>9277</fpage><lpage>9285</lpage><pub-id pub-id-type="doi">10.1007/s00253-019-10165-x</pub-id><pub-id pub-id-type="pmid">31701196</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="nutrients-17-02829-f001" orientation="portrait"><label>Figure 1</label><caption><p>Effect of dietary supplementation with Control (CON), tart cherry (TC) or fructooligosaccharides (FOS) for 10 wks on: (<bold>A</bold>) body weight over time, whole body (<bold>B</bold>) fat mass, (<bold>C</bold>) lean mass, (<bold>D</bold>) bone mineral density (BMD), (<bold>E</bold>) bone mineral content (BMC), (<bold>F</bold>) bone mineral area (BMA), and (<bold>G</bold>) lumbar vertebra trabecular bone volume relative to total volume (BV/TV), (<bold>H</bold>) distal femoral trabecular BV/TV, (<bold>I</bold>) femoral midshaft cortical thickness and (<bold>J</bold>) cortical area. Data presented as mean &#177; standard error (SE). For body weight (<bold>A</bold>), means that do not share the same superscript letter at a given timepoint are statistically different from each other. In all other figures, bars not sharing the same superscript letter differ significantly (<italic toggle="yes">p</italic> &lt; 0.05, one-way ANOVA with Tukey&#8217;s post hoc test).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nutrients-17-02829-g001.jpg"/></fig><fig position="float" id="nutrients-17-02829-f002" orientation="portrait"><label>Figure 2</label><caption><p>Dietary tart cherry (TC) and fructooligosaccharides (FOS) alter systemic biomarkers of bone formation and IGF axis regulation: (<bold>A</bold>) <italic toggle="yes">C</italic>-terminal telopeptide of type I collagen (CTX-I), (<bold>B</bold>) procollagen type I N-terminal propeptide (P1NP), (<bold>C</bold>) insulin-like growth factor 1 (IGF-1), (<bold>D</bold>) IGF-binding protein 3 (IGFBP-3), and (<bold>E</bold>) IGF-1/IGFBP-3 ratio. Data are presented as mean &#177; standard error (SE). Bars not sharing the same superscript letter differ significantly (<italic toggle="yes">p</italic> &lt; 0.05, one-way ANOVA with post hoc test).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nutrients-17-02829-g002.jpg"/></fig><fig position="float" id="nutrients-17-02829-f003" orientation="portrait"><label>Figure 3</label><caption><p>Effects of dietary supplementation with control (CON), tart cherry (TC), or fructooligosaccharides (FOS) on gut microbiota composition and short-chain fatty acids (SCFAs) concentrations. Alpha diversity assessed using the Shannon index (<bold>A</bold>), and beta diversity (<bold>B</bold>) based on Jaccard distances. Relative abundance at the phylum level (<bold>C</bold>), with specific differences highlighted for <italic toggle="yes">Actinobacteriota</italic> (<bold>D</bold>) and <italic toggle="yes">Deferribacterota</italic> (<bold>E</bold>). Relative abundance at the family level (<bold>F</bold>), and selected taxa including <italic toggle="yes">Clostridia_UCG_014</italic> (<bold>G</bold>), <italic toggle="yes">Peptostreptococcaceae</italic> (<bold>H</bold>), <italic toggle="yes">Ruminococcaceae</italic> (<bold>I</bold>), <italic toggle="yes">Anaerovoracaceae</italic> (<bold>J</bold>), and <italic toggle="yes">Deferribacteraceae</italic> (<bold>K</bold>). SCFA concentrations measured include acetic acid (<bold>L</bold>), propionic acid (<bold>M</bold>), butyric acid (<bold>N</bold>), and valeric acid (<bold>O</bold>). Microbiota composition was analyzed using ANCOM-BC with Benjamini&#8211;Hochberg correction for multiple comparisons. SCFA concentrations were analyzed by one-way ANOVA. Data are presented as mean &#177; standard error (SE). Bars not sharing the same superscript letter differ significantly (<italic toggle="yes">p</italic> &lt; 0.05).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nutrients-17-02829-g003.jpg"/></fig><fig position="float" id="nutrients-17-02829-f004" orientation="portrait"><label>Figure 4</label><caption><p>Relative abundance of T lymphocyte subsets in the lamina propria of the ileum following 10 weeks of dietary intervention with control (CON), tart cherry (TC), or fructooligosaccharides (FOS). Flow cytometry (FACS) was used to assess the percentage of (<bold>A</bold>) CD4<sup>+</sup> T cells, (<bold>B</bold>) CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> regulatory T cells (Tregs), and (<bold>C</bold>) CD4<sup>+</sup>ROR&#947;t<sup>+</sup>IL-17A<sup>+</sup> T helper 17 cells (Th17). Absolute counts were determined for (<bold>D</bold>) CD3<sup>+</sup> T cells, (<bold>E</bold>) CD4<sup>+</sup> T cells, (<bold>F</bold>) CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> Tregs, (<bold>G</bold>) CD4<sup>+</sup>ROR&#947;t<sup>+</sup>IL-17A<sup>+</sup> Th17 cells, and (<bold>H</bold>) the Treg-to-Th17 cell ratio. Data are presented as mean &#177; standard error (SE). Bars not sharing the same superscript letter differ significantly (<italic toggle="yes">p</italic> &lt; 0.05, one-way ANOVA with post hoc test).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nutrients-17-02829-g004.jpg"/></fig><fig position="float" id="nutrients-17-02829-f005" orientation="portrait"><label>Figure 5</label><caption><p>Dietary supplementation with control (CON), tart cherry (TC), or fructooligosaccharides (FOS) alters indices of dynamic bone formation, mineralization, osteoblasts, and osteocytes within the trabecular bone. (<bold>A</bold>) Bone formation rate per bone surface (BFR/BS), (<bold>B</bold>) mineral apposition rate (MAR), (<bold>C</bold>) mineralizing surface per bone surface (MS/BS), (<bold>D</bold>) osteoblast number, (<bold>E</bold>) osteoblast perimeter normalized to bone perimeter (Osteoblast/B.Pm), (<bold>F</bold>) osteocyte number, and (<bold>G</bold>) osteocyte density (osteocytes per bone area, BA). Representative silver nitrate staining of (<bold>H</bold>) trabecular and (<bold>I</bold>) cortical bone is also shown with the box at 40X noting the region shown in the enlarged box. Data are presented as mean &#177; standard error (SE). (Data was analyzed using <italic toggle="yes">t</italic>-test with bars for each significant pairwise comparison, * <italic toggle="yes">p</italic> &lt; 0.05, ** <italic toggle="yes">p</italic> &lt; 0.01, *** <italic toggle="yes">p</italic> &lt; 0.001, **** <italic toggle="yes">p</italic> &lt; 0.0001).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nutrients-17-02829-g005.jpg"/></fig><fig position="float" id="nutrients-17-02829-f006" orientation="portrait"><label>Figure 6</label><caption><p>Effects of prebiotics and antibiotic (ABX) treatment on bone. Mice were fed control (CON), tart cherry (TC), or fructooligosaccharide (FOS) diets for 10 weeks, with or without ABX. Bone parameters assessed included: (<bold>A</bold>) whole body bone mineral density (BMD), (<bold>B</bold>) femur midshaft cortical thickness and (<bold>C</bold>) area, (<bold>D</bold>) femur trabecular bone volume fraction (BV/TV), and (<bold>E</bold>) vertebra trabecular BV/TV. Data were analyzed using two-way ANOVA. Where no significant interaction was observed, <italic toggle="yes">p</italic>-values for main effects of diet or ABX are shown. Bars are mean + SE. Bars not sharing the same superscript letter are significantly different from each other (<italic toggle="yes">p</italic> &lt; 0.05).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nutrients-17-02829-g006.jpg"/></fig><table-wrap position="float" id="nutrients-17-02829-t001" orientation="portrait"><object-id pub-id-type="pii">nutrients-17-02829-t001_Table 1</object-id><label>Table 1</label><caption><p>ABX Effects on Bone and SCFA Profiles in Mice on Control Diet.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">No ABX</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">ABX</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Bone Densitometry</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;&#160;&#160;&#160;&#160;BMD (mg/cm<sup>2</sup>)</td><td align="center" valign="middle" rowspan="1" colspan="1">52.48 &#177; 0.37</td><td align="center" valign="middle" rowspan="1" colspan="1">50.00 &#177; 0.51</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;&#160;&#160;&#160;&#160;BMC (mg)</td><td align="center" valign="middle" rowspan="1" colspan="1">48.41 &#177; 0.82</td><td align="center" valign="middle" rowspan="1" colspan="1">44.67 &#177; 1.00</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0043</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;&#160;&#160;&#160;&#160;BMA (cm<sup>2</sup>)</td><td align="center" valign="middle" rowspan="1" colspan="1">9.22 &#177; 0.12</td><td align="center" valign="middle" rowspan="1" colspan="1">8.54 &#177; 0.15</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0012</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Vertebra Trabecular Bone</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;&#160;&#160;&#160;&#160;BV/TV (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">24.28 &#177; 0.89</td><td align="center" valign="middle" rowspan="1" colspan="1">26.67 &#177; 1.12</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1193</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;&#160;&#160;&#160;&#160;TbTh (&#181;m)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.058 &#177; 0.0009</td><td align="center" valign="middle" rowspan="1" colspan="1">0.056 &#177; 0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">0.2304</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;&#160;&#160;&#160;&#160;TbN (1/mm<sup>2</sup>)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.32 &#177; 0.12</td><td align="center" valign="middle" rowspan="1" colspan="1">4.87 &#177; 0.12</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0013</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;&#160;&#160;&#160;&#160;TbSp (&#181;m)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.23 &#177; 0.007</td><td align="center" valign="middle" rowspan="1" colspan="1">0.19 &#177; 0.006</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0009</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Femur Trabecular Bone</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;&#160;&#160;&#160;&#160;BV/TV (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">7.9 &#177; 0.34</td><td align="center" valign="middle" rowspan="1" colspan="1">8.64 &#177; 0.61</td><td align="center" valign="middle" rowspan="1" colspan="1">0.3545</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;&#160;&#160;&#160;&#160;TbTh (&#181;m)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.049 &#177; 0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">0.048 &#177; 0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">0.4017</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;&#160;&#160;&#160;&#160;TbN (1/mm<sup>2</sup>)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.36 &#177; 0.04</td><td align="center" valign="middle" rowspan="1" colspan="1">3.55 &#177; 0.06</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0498</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;&#160;&#160;&#160;&#160;TbSp (&#181;m)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.29 &#177; 0.004</td><td align="center" valign="middle" rowspan="1" colspan="1">0.27 &#177; 0.004</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0521</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Femur Cortical Bone</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;&#160;&#160;&#160;&#160;Cortical thickness (&#181;m)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.21 &#177; 0.003</td><td align="center" valign="middle" rowspan="1" colspan="1">0.20 &#177;0.003</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1349</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;&#160;&#160;&#160;&#160;Cortical area (&#181;m<sup>2</sup>)</td><td align="center" valign="middle" rowspan="1" colspan="1">16.28 &#177; 0.19</td><td align="center" valign="middle" rowspan="1" colspan="1">15.03 &#177; 0.86</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0343</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;&#160;&#160;&#160;&#160;Cortical porosity (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.5 &#177; 0.06</td><td align="center" valign="middle" rowspan="1" colspan="1">3.6 &#177; 0.04</td><td align="center" valign="middle" rowspan="1" colspan="1">0.4486</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Serum Bone Biomarkers</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;&#160;&#160;&#160;&#160;CTX-I (ng/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">14.51 &#177; 0.58</td><td align="center" valign="middle" rowspan="1" colspan="1">11.89 &#177; 0.78</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0410</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;&#160;&#160;&#160;&#160;P1NP (ng/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">16.07 &#177; 1.39</td><td align="center" valign="middle" rowspan="1" colspan="1">15.25 &#177; 1.94</td><td align="center" valign="middle" rowspan="1" colspan="1">0.7427</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;&#160;&#160;&#160;&#160;IGF-I (pg/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">386,870 &#177; 24,488</td><td align="center" valign="middle" rowspan="1" colspan="1">307,533 &#177; 40,932</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0629</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;&#160;&#160;&#160;&#160;IGFBP-3 (pg/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">280,663 &#177; 20,424</td><td align="center" valign="middle" rowspan="1" colspan="1">275,261 &#177; 30,444</td><td align="center" valign="middle" rowspan="1" colspan="1">0.9155</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;&#160;&#160;&#160;&#160;IGF-I/IGFBP-3 (pg/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.42 &#177; 0.09</td><td align="center" valign="middle" rowspan="1" colspan="1">1.03 &#177; 0.10</td><td align="center" valign="middle" rowspan="1" colspan="1">0.2558</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Fecal SCFAs (&#181;mol/g)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;&#160;&#160;&#160;&#160;Acetic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">8.43 &#177; 0.46</td><td align="center" valign="middle" rowspan="1" colspan="1">6.84 &#177; 0.97</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1047</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;&#160;&#160;&#160;&#160;Propionic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">0.95 &#177; 0.07</td><td align="center" valign="middle" rowspan="1" colspan="1">0.69 &#177; 0.05</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0016</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#8195;&#160;&#160;&#160;&#160;Butyric acid</td><td align="center" valign="middle" rowspan="1" colspan="1">0.57 &#177; 0.05</td><td align="center" valign="middle" rowspan="1" colspan="1">0.38 &#177; 0.03</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0399</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8195;&#160;&#160;&#160;&#160;Valeric acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.20 &#177; 0.01</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.12 &#177; 0.03</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0065</td></tr></tbody></table><table-wrap-foot><fn><p>Data presented as mean &#177; SE. n = 8/group. Abbreviations: No ABX = Control diet without antibiotics in drinking water; ABX = Control diet with antibiotics in drinking water. (<italic toggle="yes">p</italic> &lt; 0.05, <italic toggle="yes">t</italic>-test).</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="nutrients-17-02829-t002" orientation="portrait"><object-id pub-id-type="pii">nutrients-17-02829-t002_Table 2</object-id><label>Table 2</label><caption><p>Fecal SCFA and gDNA Concentrations.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">CON</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">TC</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">FOS</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1"><italic toggle="yes">p</italic>-Values</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No ABX</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ABX</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No ABX</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ABX</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No ABX</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ABX</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DIET</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ABX</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diet &#215; ABX</th></tr></thead><tbody><tr><td colspan="3" align="left" valign="middle" rowspan="1">Fecal SCFAs (&#181;mol/g)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#160;&#160;Acetic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">8.4 &#177; 0.5 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">6.9 &#177; 1.0 <sup>bc</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">8.6 &#177; 1.1 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3.6 &#177; 0.2 <sup>cd</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">14.5 &#177; 2. 5 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3.1 &#177; 0.2 <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.0095</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#160;&#160;Propionic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">1.0 &#177; 0.17 <sup>bc</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.7 &#177; 0.1 <sup>cd</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.2 &#177; 0.1 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.5 &#177; 0.1 <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2.2 &#177; 0.3 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.6 &#177; 0.1 <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.0002</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0002</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#160;&#160;Butyric acid</td><td align="center" valign="middle" rowspan="1" colspan="1">0.6 &#177; 0.05 <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.4 &#177; 0.0 <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.0 &#177; 0.1 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.3 &#177; 0.1 <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.9 &#177; 0.1 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.3 &#177; 0.0 <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.0004</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#160;&#160;Valeric acid</td><td align="center" valign="middle" rowspan="1" colspan="1">0.2 &#177; 0.0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1 &#177; 0.0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.2 &#177; 0.0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1 &#177; 0.0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.3 &#177; 0.0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1 &#177; 0.0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.7281</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0786</td></tr><tr><td colspan="2" align="left" valign="middle" rowspan="1">gDNA Conc (ng/&#956;L)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="3" align="center" valign="middle" rowspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#160;&#160;Cecal</td><td align="center" valign="middle" rowspan="1" colspan="1">142.7 &#177; 34.1 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">13.5 &#177; 2.5 <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">150.1 &#177; 40.6 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7.8 &#177; 0.7 <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">237.0 &#177; 36.1 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">48.4 &#177; 9.2 <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0276</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#160;&#160;Fecal</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">144.1 &#177; 8.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">51.0 &#177; 2.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">174.4 &#177; 24.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">55.8 &#177; 21.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">191.3 &#177; 10.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">146.8 &#177; 18.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0013</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1031</td></tr></tbody></table><table-wrap-foot><fn><p>Data are presented as mean &#177; standard error (SE). Abbreviations: CON, control diet; TC, tart cherry diet; FOS, fructooligosaccharide diet; ABX, antibiotics. Statistical significance was defined as <italic toggle="yes">p</italic> &lt; 0.05 for main effects of diet or ABX, and for diet &#215; ABX interactions. The superscript letters differ significantly.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="nutrients-17-02829-t003" orientation="portrait"><object-id pub-id-type="pii">nutrients-17-02829-t003_Table 3</object-id><label>Table 3</label><caption><p>Effects of Diet and Antibiotic Treatment on Femoral and Lumbar (L5) Vertebral Bone Microarchitecture.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">CON</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">TC</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">FOS</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1"><italic toggle="yes">p</italic>-Values</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No ABX</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ABX</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No ABX</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ABX</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No ABX</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ABX</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DIET</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ABX</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diet &#215; ABX</th></tr></thead><tbody><tr><td colspan="2" align="left" valign="middle" rowspan="1">L5 Trabecular Bone</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#160;&#160;BV/TV (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">24.29 &#177; 0.90</td><td align="center" valign="middle" rowspan="1" colspan="1">26.68 &#177; 1.12</td><td align="center" valign="middle" rowspan="1" colspan="1">27.24 &#177; 0.84</td><td align="center" valign="middle" rowspan="1" colspan="1">28.36 &#177; 1.53</td><td align="center" valign="middle" rowspan="1" colspan="1">34.23 &#177; 0.93</td><td align="center" valign="middle" rowspan="1" colspan="1">37.43 &#177; 1.21</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0169</td><td align="center" valign="middle" rowspan="1" colspan="1">0.6458</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#160;&#160;TbN (1/mm<sup>2</sup>)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.32 &#177; 0.12</td><td align="center" valign="middle" rowspan="1" colspan="1">4.88 &#177; 0.12</td><td align="center" valign="middle" rowspan="1" colspan="1">4.56 &#177; 0.13</td><td align="center" valign="middle" rowspan="1" colspan="1">4.90 &#177; 0.07</td><td align="center" valign="middle" rowspan="1" colspan="1">4.64 &#177; 0.13</td><td align="center" valign="middle" rowspan="1" colspan="1">4.91 &#177; 0.11</td><td align="center" valign="middle" rowspan="1" colspan="1">0.3074</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0002</td><td align="center" valign="middle" rowspan="1" colspan="1">0.4321</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#160;&#160;TbTh (mm)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.06 &#177; 0.00 <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.06 &#177; 0.00 <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.06 &#177; 0.00<sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.06 &#177; 0.00 <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.07 &#177; 0.00 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.07 &#177; 0.00 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">0.5109</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0035</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#160;&#160;TbSp (mm)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.23 &#177; 0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">0.20 &#177; 0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">0.22 &#177; 0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">0.20 &#177; 0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">0.21 &#177; 0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">0.19 &#177; 0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0765</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">0.7162</td></tr><tr><td colspan="2" align="left" valign="middle" rowspan="1">Femur Trabecular Bone</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#160;&#160;BV/TV (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">7.90 &#177; 0.34 <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">8.64 &#177; 0.61 <sup>cd</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">9.93 &#177; 0.62 <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">11.87 &#177; 0.75 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">12.16 &#177; 0.72 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">19.09 &#177; 0.78 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0150</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#160;&#160;TbN (1/mm<sup>2</sup>)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.37 &#177; 0.05 <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3.55 &#177; 0.07 <sup>cd</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3.63 &#177; 0.04 <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">4.00 &#177; 0.09 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3.98 &#177; 0.09 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">4.65 &#177; 0.10 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0316</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#160;&#160;TbTh (mm)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.05 &#177; 0.00</td><td align="center" valign="middle" rowspan="1" colspan="1">0.05 &#177; 0.00</td><td align="center" valign="middle" rowspan="1" colspan="1">0.05 &#177; 0.00</td><td align="center" valign="middle" rowspan="1" colspan="1">0.05 &#177; 0.00</td><td align="center" valign="middle" rowspan="1" colspan="1">0.05 &#177; 0.00</td><td align="center" valign="middle" rowspan="1" colspan="1">0.05 &#177; 0.00</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0009</td><td align="center" valign="middle" rowspan="1" colspan="1">0.5483</td><td align="center" valign="middle" rowspan="1" colspan="1">0.7425</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#160;&#160;TbSp (mm)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.29 &#177; 0.00 <sup>c</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.28 &#177; 0.01 <sup>ab</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.27 &#177; 0.00 <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.24 &#177; 0.01 <sup>c</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.24 &#177; 0.01 <sup>c</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.19 &#177; 0.01 <sup>d</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0091</td></tr></tbody></table><table-wrap-foot><fn><p>Data are presented as mean &#177; standard error (SE). Abbreviations: CON, control diet; TC, tart cherry diet; FOS, fructooligosaccharide diet; ABX, antibiotics. Statistical significance was defined as <italic toggle="yes">p</italic> &lt; 0.05 for main effects of diet or ABX, and for diet &#215; ABX interactions. The superscript letters differ significantly.</p></fn></table-wrap-foot></table-wrap></floats-group></article></pmc-articleset>